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EXPLANATION OF THESIS FORMAT 
This is an alternate format thesis. The thesis begins with a general 
introduction and literature review followed by two separate manuscripts. A 
general summary and discussion concludes the thesis. The master's candidate, 
Richard Hill, is the senior author and principal investigator of the study. 
1 
GENERAL INTRODUCTION 
Rabies virus is capable of infecting all warm blooded animals and with the 
exception of a few countries, is found worldwide. Today, sylvatic rabies is present 
throughout the continental United States. As domestic animal control programs 
eliminated canine rabies, wildlife host ranges expanded and increased numbers of 
wildlife cases were reported. Laboratory confirmed cases of rabies are most 
common in the skunk, raccoon, fox, and bat (Smith, 1989). In the last 30 years, 
the raccoon bas emerged as a new reservoir host. Two epizootics of raccoon 
rabies have occurred in the southeastern and mid-Atlantic areas of the United 
States. Since 1982, the raccoon has been the second most commonly reported 
rabid wildlife species (Baer et al., 1990). 
Rabies in raccoons is not currently a problem in Iowa, and is only 
sporadically reported in the central United States. Serologic investigations have 
shown that the prevalence of serum neutralizing antibodies in raccoons in areas 
without enzootic raccoon rabies is higher than the prevalence of the disease as 
reported by public health laboratories (McLean, 1975; Niemeyer, 1973). The role 
of the raccoon in the maintenance and transmission of rabies in areas without 
enzootic raccoon rabies is only partially understood. Raccoon susceptibility to the 
skunk virus bas not been reported. 
The purpose of tbjs study was to investigate the prevalence and nature of 
serum neutralizing antibodies in raccoons in two counties in Iowa and investigate 
the behavior of a skunk rabies isolate in this species. 
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LITERATURE REVIEW 
History 
The origin of the term rabies is from Latin rabere - to rave (Beran, 1981). 
Rabere is derived from an old Sanskrit term rabhas - to do violence (Steele, 
1975). Beran and Wilkinson report that the first recorded description of rabies 
comes from the Sumerian law code from the city of Eshnunna in approximately 
2000 BC. References are made to penalties dog owners must pay if dogs known 
to be mad, bite persons after authorities bad warned the owner of the risks of not 
caging their animaJs (Beran, 1981; Wilkinson, 1988). This indicates an early 
recognition of the transmissibility and severity of the disease and the public 
health benefits associated with attempting to limit the spread of the disease. 
Other early descriptions of canine rabies are found in the writings of 
Democritus and Hippocrates in the 5'b century BC (Smithcors, 1958). Aristotle 
also described canine rabies about 340 BC, but incorrectly assumed it could not 
be transmitted to people (Smitbcors, 1958). The Roman, Cardanus, was the first 
to recognize the infectivity of the saJiva and described the infectious agent as a 
poison (Steele, 1975; Wiktor, 1985). There are numerous other accounts of 
rabies in ancient times (Beran, 1981; Smithcors, 1958; Steele, 1975; Wilkinson, 
1988), most of which refer to the dangers of dog bites and the recognition that 
the disease is spread via the bite wound. In approximately 100 AD, Celsus made 
references to rabies in wild and domestic animals and people (Steele, 1975; 
Wilkinson, 1988; Wiktor, 1985). Being a physician, he recommended cupping or 
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suclcing the wound followed by heat cautery, caustics, salt, or blood letting as 
treatments. Soran.us, a Greek physician, also reported the possibility of wild 
animals transmitting the disease (Steele, 1975). 
In the centuries that followed, many preventive and post-exposure 
treatments were proposed (Beran, 1981; Steele, 1975; Willcinson, 1988). Such 
references demonstrate that the disease was well understood, but considering the 
medical skills of the times, little could be done excepting local treatment of the 
wound. Assorted treatments included hot and cold water baths, oil treatments to 
the wound, application of goose grease or honey to the wound, consumption of 
large quantities of wine, eating cock's brains or the salted flesh of the rabid dog, 
and countless other assorted superstitious treatments (Steele, 1975). 
Reports of world wide epidemics of canine rabies from the 1500s to the 
1800s are well documented (Beran, 1981; Smithcors, 1958; Steele, 1975). In the 
United States, early reports of canine rabies came from Virginia in 1753, North 
Carolina in 1762 (Beran, 1981; Smithcors, 1957), Boston in 1768, and 
Pennsylvania and Maryland by 1799 (Smithcors, 1957). In 1779, James Mease, a 
Pennsylvania physician published a work: On the Disease Produced by the Bite 
of a Mad Dog, insisting the only way to spread the disease was by a bite wound 
(Srnithcors, 1957). Following the Civil War, canine rabies was widespread in 
most of the United States (Beran, 1981; Smithcors, 1958; Tierkel, 1975). 
Similarly, world wide outbreaks of wildlife rabies were being reported. Wolf 
rabies was recognized as early as the 12'b century in France and the 13•h century 
in Germany and Asia (Beran, 1981; Smithcors, 1958). As early as 1576, Spanish 
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explorers reported bat rabies in Central and Sou th America, and death in cattle 
following the bites of bats (Beran, 1981; Baer, 1975b). In North America, early 
Eskimo folklore describes a disease in foxes fitting the description of rabies which 
could be transmitted to dogs and people (Beran, 1981). By the 1700s rabies was 
enzootic in foxes in the eastern United States (Winkler, 1975). Rabies was 
recognized in several other terrestrial wildlife species across the United States by 
the 1800s (Beran, 1981; Parker, 1975; Winkler, 1975). 
Attempts to control epidemics of rabies were aimed at the dog and included 
population reductions, animal control, and muzzling orders imposed and 
regulated by governmental authorities (Beran, 1981; Steele, 1975). With few 
exceptions, most of these attempts were unsuccessful (Steele, 1975). One 
exception was the successful rabies eradication in Great Britain by 1902 using 
these methods (Steele, 1975). 
It was not until the late 1800s with the research of Pasteur and his co-
workers that dramatic changes occurred in the world wide picture of rabies. With 
the exception of animal avoidance and the treating of bite wounds, little changed 
until the advent of the first effective post-exposure prophylactic vaccine by 
Pasteur in 1885 (Beran, 1981; Steele, 1975; Wiktor, 1985). Beginning in 1881 
with the experimental transfer of infection by nervous tissue, Pasteur, without 
knowledge of the causative agent, created an attenuated vaccine using dried 
pieces of spinal cord from rabbits infected with virus with a fixed incubation 
period of seven days (Steele, 1975; Wiktor, 1985). Pasteur's immunization 
protocol consisted of injecting preparations of spinal cord which had been dried 
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for 14 and subsequently fewer days (Beran, 1981; Steele, 1975). 
In the last 105 years since the development of a successful human vaccine, 
there have been numerous accomplishments in the areas of rabies control. One 
of the first vaccines to be widely used in domestic animals was a vaccine 
produced from fresh rabbit spinal cords in 1898 by Hogyes (Bunn, 1988). In 
1908, Fermi developed a phenolized vaccine which was more stable than the 
spinal cord preparations of Pasteur (Steele, 1975). Semple continued the work on 
an inactivated vaccine and produced a highly antigenic phenolized vaccine in 1911 
(Beran, 1981). In 1955, Fuenzalida and Palacios reported an inactivated suckling 
mouse brain vaccine which decreased the demyelinating neuroparalytic hazards of 
other vaccines made from nervous tissue origin (Beran, 1981; Kaeberle, 1958; 
Wiktor, 1985). Since then, many different types of rabies vaccine have been 
prepared from nerve tissue of animal origin. In addition to using these vaccines 
for human beings, mass dog vaccination programs as a means of rabies control 
were started as early as 1919 (Bunn, 1988). 
Modified live virus vaccines of avian embryo origin were developed in 1948 
(Koprowski and Cox, 1948). Steele reports that these vaccines resulted from 
early successes of Dawson in 1930 and Bernkopf and Kligler in 1940 in growing 
rabies virus in developing embryos (Steele, 1975). Mass application of these 
potent vaccines in the late 1940s and early 1950s led to a significant decrease in 
canine rabies in many parts of the world (Baer 1990). However, cases of vaccine 
induced rabies were seen with some of these avian embryo origin vaccines 
(Pederson et al., 1978; Whetstone et al., 1984). 
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Steel reports that in 1936 there were two major developments in rabies virus 
research; the reporting of the size of the virus by Galloway and Elford and the 
first propagation of rabies virus in tissue culture by Webster and Clow (Steele, 
1975). In 1958, the rabies virus was adapted to cell culture (Kissling, 1958). 
With this new technology, extensive work on many tissue culture origin vaccines 
was done, leading to the many different types of vaccines that exist today (Beran 
1981; Bunn 1988). These newly developed vaccines bad the advantage of 
reducing excessive anaphylactic reactions caused by tissue antigens in avian 
embryo origin vaccines (Wiktor, 1985). Most of the vaccines available for 
domestic animals in the United States today are killed virus cell culture origin 
products (Bunn, 1988). 
The major emphasis in vaccine production has been for use in domestic 
animals rather that in wildlife. Baer reports that as early as 1960, work was 
started on the vaccination of wildlife species (Baer,J 988a). Effective oral vaccines 
for wildlife have been used in numerous countries throughout the world (Steck et 
al., 1982a and 1982b; Rupprecht et al., 1988). 
In addition to vaccination and control programs, the diagnosis of rabies has 
historically presented many difficulties for the medical profession (Steele, 1975). 
The finding of pathognomonic Negri bodies by Negri in 1903 was a key event in 
diagnosis (Baer et al., 1990). Although he had incorrectly identified these 
inclusion bodies as protozoa, he had identified the horn of Ammon as the site of 
predilection (Steele, 1975). Later in 1927, Sellers demonstrated that Negri bodies 
could be identified in impression preparations of brain tissue (Steele, 1975). 
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The next advance in rabies diagnosis was the mouse inoculation test 
(Webster and Dawson, 1935). This test has become the accepted standard and is 
widely used today. A similar test capable of appraising the potency of vaccines 
was developed by Habel in 1940 (Beran, 1981; Bunn, 1988). The fluorescent 
antibody (FA) test also had a significant impact on rabies diagnostic procedures. 
Goldwasser and Kissling reported the development of a FA test for the diagnosis 
of rabies in central nervous system tissue in 1958 (Goldwasser and Kissling, 1958). 
Several other diagnostic tests have been adapted to aid in the diagnosis of rabies 
in other tissues, and numerous serologic tests have been developed (Webster and 
Casey, 1988). These and other recent accomplishments are discussed separately 
in following sections. 
Etiology 
Rabies viruses are members of the family Rhabdoviridae and are considered 
the type species of the genus Lyssavirus (Baer et al., 1990; Wagner, 1990). They 
are believed to have originated in Africa (Beran, 1981). Rbabdoviruses are 
enveloped bullet shaped RNA virions that measure an average of 75 by 180 nm 
(Wunner et al., 1988). They are found worldwide and afflict over 100 species 
including plants, reptiles, fish , crustaceans and mammals (Baer et al., 1990). In 
addition to rabies virus, five other viruses in the genus Lyssaviruses are commonly 
referred to as the rabies-related organisms. These include Duvenhage, Kotonkan, 
Lagos Bat, Mokola and Obodhiang viruses (Beran, 1981; Kaplan, 1985; Shope, 
1975; King and Crick, 1988). Monoclonal antibody studies have allowed 
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classification of the Lyssaviruses into four rustinct serotypes (World Health 
Organization, 1984). Serotype 1 includes the prototype strain Challenge Virus 
Standard (CVS) and the majority of laboratory and field strains. Serotypes 2, 3, 
and 4 are the rabies-related viruses. Other viruses such as the Nigerian horse 
virus, Ouluo-Fato, Bolivar and Rodent virus have also been reported to have 
morphological and serological relatedness to rabies virus (Kaplan, 1985; Nawathe 
and Lamorde, 1982). Monoclonal antibodies directed against nucleocapsid and 
glycoprotein antigens have allowed further classification of different virus strains 
(Smith et al., 1986). 
Virus Structure. Function and Characteristics 
The virus consists of nucleic acid and five proteins (G, N, Ml, M2 and L) 
(World Health Organization, 1984). The virions are bound in a lipoprotein (lipid 
and M2 protein) envelope which has glycoprotein G transmembrane spikes 
(Greene et al., 1984, Crick and King, 1988, Tordo and Poch, 1988). The 69 
kilodalton (kDa) G-protein is the only polypeptide that is glycosolated and 
completely spans the envelope (Wunner, 1985). There are no spikes on the 
planar end of the virion (Wunner, 1985). 
Glycoprotein G is responsible for induction and binding of virus neutralizing 
antibodies and protection of animals against challenge. In addition, the 
glycoprotein is responsible for mediating attachment of the virus to host cells, 
determining virulence and stimulating T cells which express suppressor, helper, or 
cytotoxic activities (Baer et al., 1990; Crick, 1985; Dietzschold et al., 1985). The 
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nucleotide sequence of the G protein bas been determined for several strains 
(Tordo and Poch, 1988; Dietzschold et al., 1985). Monoclonal antibodies have 
been used to construct operational antigenic maps of the rabies glycoproteins 
(Flamand et al., 1980b; Lafon et al., 1984). Three functionally independent 
antigenic sites in CVS-11 and five distinct sites in the Street Alabama Dufferin 
(SAD) strain have been defined (Wunner et al., 1988). There is also evidence of 
new antigenic sites on both the CVS and SAD strains (Bunschoten et al., 1989). 
The core of the virus particle is a tightly structured ribonucleoprotein helix 
consisting of the RNA genome and the internal proteins (Wunner et al., 1988). 
The genome is unsegmented single stranded non-infectious RNA of negative 
polarity with a molecular weight estimated at 3.5 to 4.6 x 106 Daltons (Crick and 
King, 1988; Tordo and Poch, 1988). The complete sequence of 11932 nucleotides 
bas been determined (Tordo and Poch, 1988). 
Within the ribonucleoprotein complex are approximately 1,800 copies of the 
55 kDa phospborylated N protein core in association with approximately 900 
copies of the 400 kDa Ml protein and 30-60 copies of 244 kDa L protein (Baer 
et al., 1990; Crick and King, 1988; Dietzschold et al., 1985). A matrix M2 protein 
on the inner side of the lipid envelope interacts with both the lipid bilayer and 
the ribonucleoprotein core (Tordo and Poch, 1988). The N protein contains the 
cross reactive group specific antigen of the rabies group of viruses and is 
responsible for shared complement fixing, imrnunoprecipitation and 
immunofluorescence tests of these viruses (Beran, 1981; Baer et al., 1990; 
Dietzschold et al., 1985). The N protein also plays a ro le in the induction of 
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protective antibody titer (Dietzschold et al., 1987). The M-proteins are thought 
to play a role in the budding process (Baer et al., 1990). Monoclonal antibody 
studies have identified distinct antigenic sites in the nucleoprotein (Flamand et 
al., 1980a). 
Chemical analysis reveals that purified virus contains 3-4% RNA, 67% 
protein, 3% carbohydrate associated with proteins and 26% lipid (Schneider and 
Diringer, 1976; Sokol, 1975). The virus is inactivated by lipid solvents, 45-70% 
ethanol, iodine preparations and quaternary ammonium compounds (Kaplan, 
1973). The virus is unstable at pH less than 5 or greater than 10 (Clark and 
Wiktor, 1972). Desiccation, sunlight, ultraviolet and x-irradiation, trypsin, ether 
and beta-propiolactone readily inactivate the nucleic acid (Kaplan, 1973; Martin 
and Sedrnak, 1983). The virus is stable for many years when frozen at -60 to 
-80° F (Bernard and Fishbein, 1990). The virus is also stable in carrion. The 
virus survives in animal tissue for 20 days (10° C) and 8 days (25° C) (Soave, 
1966). 
Clinical Signs 
Rabies virus is capable of infecting all warm blooded animals, but species 
susceptibility varies considerably (World Health Organization, 1973). Opossums 
appear least susceptible; moderately susceptible are dogs, human beings and most 
wildlife reservoirs. Foxes, coyotes, jackals and wolves appear most susceptible 
(Baer et al., 1990; World Health Organization, 1984). The rate of spread differs 
with species and with age (Martin and Sedmak, 1983). Incubation periods are 
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highly variable and are dependent upon many factors such as site of bite, 
innervation at bite site, amount of virus injected, species bitten, immune status, 
species adapted variant of virus and age of host (Acha and Szyfrez, 1987; Baer et 
al., 1990; Charlton, 1988; Greene et al., 1984). Examples of the variability of 
these factors have been demonstrated; incubation periods are shorter in bites to 
the head (Baer et al., 1990), and young dogs are more susceptible than adults 
(Tierkel, 1975). 
On a worldwide basis, dogs are the major reservoir of rabies in animals 
(Beran, 1981). They have been considered the prototype species for the 
pathogenesis of the disease (Tierkel, 1975). Clinical signs are divided into three 
major stages; prodromal, excitement and paralytic. The incubation period is 
usually three to eight weeks, but periods as short as 11 days, or as long as six 
months are documented (Beran, 1981; Fekadu et al., 1982). The prodromal 
phase generally lasts for two days with behavior changes, apprehension and 
temperament changes most commonJy reported (Beran, 1981; Greene et al., 
1984). The excitement phase usually lasts for one to seven days, but may be so 
transient that it is unrecognizable (Greene et al., 1984). Clinical signs include 
restlessness, irritability, increased responses to auditory and visual stimuli, 
pbotophobia and snapping at imaginary objects. As dogs become more restless, 
they become more irritable and vicious (Beran, 1981; Greene et al., 1984). The 
paralytic phase usually lasts from one to four days. Progressive paralysis starts in 
the area of exposure, posterior extremities, or the lower jaw (Beran, 1981; Tierkel 
1975). Cranial nerve paralysis is seen where bites have occurred around the face 
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(Baer et al., 1990). Salivation, excessive frothing and dropped jaw may occur with 
paralysis of the masticatory and laryngeal muscles (Tierkel, 1975). Paralysis 
spreads rapidly to the rest of the body, and death follows as a result of coma and 
paralysis of respiratory muscles. Rare abortive forms of the disease have been 
documented (Fekadu and Baer, 1980). 
The phases of disease in other animals are comparable to the dog with 
variability among species (Beran, 1981; Greene et al., 1984; Kaplan, 1985). 
Notable changes in other species include the excitement phase seen in a majority 
of cats and unusual behavior changes commonly associated with wildlife species 
(Beran, 1981; Greene et al., 1984). Many wild animals lose their fear of people, 
and nocturnal animals come out in daylight (Beran, 1981; McLean, 1975). 
Pathogenesis 
Several distinct steps are involved in the pathogenesis of rabies as the virus 
moves through the body (Charlton, 1988). These include introduction of the virus 
via a bite wound, laceration and less commonly mucus membranes; migration via 
peripheral nerves to the central nervous system (CNS); and centrifugal neural 
transport and infection of non-nervous tissue (Charlton, 1988). Following 
inoculation into a muscle field, the virus can onJy be recovered for a limited 
period of time, usually Jess than 24 hours (Baer, 1975a; Charlton, 1988; Tsiang, 
1988). The virus becomes sequestered followed by replication in monocytes 
(Baer et al., 1990; Beran, 1981; Murphy, 1985). Virus penetration into host cells 
is either by adsorptive endocytosis or by direct fusion with cell membranes 
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(Tsiang, 1988). During this initial period, there is an eclipse phase where neither 
antigen nor virus can be identified (Baer et al., 1990). Commonly, there is no 
virernia unless it follows a high inoculum dose in experimental animals (Murphy, 
1985). 
Next, the virus traverses neuromuscular and neurotendinous spindles to 
approach peripheral nerves (Murphy, 1985). The mechanisms of neuromuscular 
virus passage are not clear. Acetylcholine receptors on the virus have been 
suggested as one method of facilitating cellular uptake (Baer et al., 1990; 
Charlton, 1988). Other researchers have concluded that rabies virus interaction 
with cell surfaces is via carbohydrate moieties, phospholipid and highly sialyated 
gangliosides which are independent of acetylcholine (Tsiang, 1988). 
The bite route is by far the most common method of transmission, but other 
routes are documented. Viral infection of olfactory epithelial cells and bipolar 
neurons extending to the olfactory bulb has been reported (Charlton, 1988). 
Aerosol transmission is reported in both humans (Winkler et al., 1973) and 
animals (Winkler et al., 1972). Viral progression to the central nervous system 
from oral mucus membranes is believed to be via the neuroepithelium of taste 
buds (Baer, 1975a). Infection via the cornea is probably through uptake of 
sensory nerve fibers and not the optic nerve (Charlton, 1988). Other unusual 
forms of pathogenesis include viral entry via the gastrointestinal route (Ramsden 
and Johnston, 1975), sequestration of virus in brown fat of bats (Martin and 
Sedmak, 1983), and lactogenic or transplacental transmission (Howard, 1984). 
Once the virus enters nerves, it is believed to progress in the tissue spaces 
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between the Schwarm cells and perineural structures (Martin and Sedmak, 1983). 
It is reported that fixed rabies virus travels at approximately 3 mm per hour 
(Dean et al., 1963). Rabies viral transport to the CNS can occur along motor or 
sensory fibers (Charlton, 1988). Blood-vascular routes have also been reported as 
means of transfer to the CNS (Baer, 1975b ). 
Viral replication occurs in the dorsal root ganglia or spinal ganglia 
corresponding to the involved peripheral nerves and then progresses rapidly to 
the CNS (Baer, 1975a). The virus may be hidden from the immune and 
inflammatory systems of the host (Murphy, 1985). Selective areas of replication 
of the virus occur in neurons, and spread of infection in the CNS is considered 
trans-neuronal via formation of virions on cell membranes (Charlton, 1988). 
There is tropism for the neuronal cells of the brainstem, hippocampus, subcortical 
nuclei, limbic cortex and Purkinje cells in the cerebellum (Charlton, 1988; Martin 
and Sedmak, 1983; Schneider, 1975a). 
Once the virus reaches the brain, peripheral nerves act as pathways for rapid 
centrifugal spread of virus throughout the enti re body (Baer, 1975a; Charlton, 
1988). This accounts for occurrences of virus in tissues and fluids before the 
onset of clinical signs (Beran, 1981; Charlton, 1988). Of all non-neural tissues, 
the salivary glands are most likely to contain the rabies virus (Schneider, 1975b ). 
The glands are infected via release and entry of the rabies virus into acinal 
epithelial cells from the terminal axons (Charlton et al., 1983). Virus budding 
from plasma membranes of mucous acinar cells delivers virus into the secretions 
(Martin and Sedmak, 1983). Rabies virus has been isolated in the saliva of dogs 
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for up to 10 months following experimental infection with a challenge prepared 
from saliva from Ethiopian dogs (Fekadu et al., 1981; Fekadu and Baer, 1980). 
Virus bas also been demonstrated in numerous other tissues and fluids (Martin 
and Sedmak, 1983). 
The majority of rabies infections progress through typical pathogenesis of 
the disease characterized by the spread of the virus, development of classical 
clinical signs and death. Although uncommon, numerous variations exist in the 
pathogenesis (Charlton, 1988). Experimentally observed variations include 
recovery from infection with or without disability (Fekadu and Baer, 1980), 
variable or prolonged incubation period (Fekadu et al., 1982), varying periods of 
clinical signs (Perl et al., 1977; Schneider 1975b ), change in type of clinical signs 
(Charlton, 1988), variations in virus excretion (Schneider, 1975b ), and 
development of the carrier state (Martin and Sedmak, 1983; Perl et al., 1977). 
Although definitive explanations for these variations have not been found, 
possibilities include route of exposure and dose of inoculum (Charlton, 1988), 
species adapted virus variants (Smith et al., 1986), genetic resistance (Lodmell, 
1988), and immunologic mechanisms (MacFarlan, 1988). 
Pathology 
A limited number of lesions are observed when considering the severity of 
the symptoms seen in rabies. Congestion of meningeal vessels is commonly the 
only gross lesion seen (Perl, 1975). Pathologic changes include encephalomyelitis 
characterized by diffuse and perivascular cuffing, neuronophagia, neural 
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degeneration and neuronal intracytoplasmic inclusion bodies (Negri bodies) 
(Atanasiu, 1975; Perl, 1975). Negri bodies are ribonucleoprotein, they appear as 
acidophilic inclusions with basophilic granules, and are most abundant in the 
central pyramidal layer of the hippocampus (Atanasiu, 1975). Special stains such 
as SelJers stain have been developed to help elucidate them (Tierkel, 1973). 
Pathologic changes vary with the stage of infection, part of the CNS affected, 
immune and inflammatory response, type of virus variant causing the disease and 
species affected (Atanasui, 1975; Baer et al., 1990; Lepine, 1973b; Perl, 1975; 
Tierkel, 1973). 
Diagnosis 
Diagnosis of rabies based on epidemiological studies or clinical signs is very 
important, but only through laboratory tests can rabies be confirmed (Baer et al., 
1990). Tests for rabies antigens or antibodies are the primary tests because 
routine chemical and hematological tests do not usually show specific 
abnormalities (Hattwick and Gregg, 1975). 
In human beings, many non-invasive antemortem tests are available (Baer et 
al., 1990), including 1) electroencephalography (EEG) which may be normal early 
in illness yet may show abnormalities as the disease progresses, 2) CNS imaging 
which may be normal or show CNS edema and increased intracranial pressure, 3) 
Examination of full thickness skin biopsy from the nape of the neck by 
fluorescent antibody technique, 4) virus isolation from saliva by mouse inoculation 
or other antigen tests, 5) FA testing of corneal impression smears, 6) detecting of 
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neutralizing antibodies in serum or cerebral spinal fluid. Many of these same 
tests can be performed in animals, but some are impractical. 
The most common post mortem diagnostic tests are antigen detection tests. 
One of the standard tests is an animal (primarily mouse) inoculation test with 
suspect brain tissue followed by FA staining (Koprowslci, 1973). This test is 
highly specific, but is time consuming and successful only on fresh or frozen 
tissues (Atanasui, 1975; Greene et al., 1984; Koprowslci, 1973). Observation of 
stained Negri bodies in fresh or formalized tissues is also highly specific, but may 
be restricted by appearance of the Negri bodies late in the course of disease. 
Also, highly virulent strains may not produce many inclusion bodies (Atanasui, 
1975; Tierkel, 1973). 
The most widely used method of antigen detection is the direct 
immunofluorescence test (Greene et al., 1984). The test is rapid and specific in 
the hands of experienced personnel (Beran and Crowley, 1983; Dean and 
Abelseth, 1973). In many laboratories, sensitivity of the results is increased by 
performing the mouse inoculation test in all FA negative samples (Dean and 
Abelseth, 1973). Immunoperoxidase and FA tests have also been adapted to an 
ante mortem test to detect antigen in corneal impression smears, tactile hair 
roots, or skin biopsies (Blenden, 1981; Blenden et al., 1983; Ciucbini et al., 1984). 
Other methods for antigen detection include cell culture inoculation 
followed by FA staining (Wiktor, 1973b), or plaque assay (Crick and King, 1988), 
enzyme immunoassay on both fresh and fixed tissues (Bourgon and Charlton, 
1987; Webster and Casey, 1988), complement fixation (Kuwert, 1973a), 
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hemagglutination (Kuwert, 1973b), gel immunoprecipitation (Lepine, 1973a), and 
electron microscopy (Hummeler and Atanasiu, 1973). Non-infections virion free 
antigen produced in cell culture can be detected by complement fixation and gel 
diffusion tests (Wiktor, 1973b ). Monoclonal antibodies directed against the 
glycoprotein and the ribonucleoprotein of matrix proteins are available to help 
identify rabies and rabies-related virus isolates (Dietzscbold et al., 1990; Wiktor 
and Koprowski, 1980). 
Where post-mortem samples are available, these tests provide confirmation 
of suspected clinical rabies and allow epidemiologic studies on the nature of the 
virus. Monoclonal antibodies directed against nucleocapsid proteins of rabies 
virus isolates have been the most helpful in epidemiologic diagnosis and analysis 
of outbreaks (Smith, 1989). 
A wide variety of serological antibody detection techniques are available. 
The virus neutralization test in mice is the accepted standard of comparison for 
all other antibody tests (Atanasiu, 1973). Fluorescent antibody techniques, 
especially the Rapid Fluorescent Focus Inhibition Test (RFFIT) (Smith et al., 
1973), are the most widely accepted alternatives to the mouse neutral ization test 
(Campbell and Barton, 1988; Martin and Sedmak, 1983). These are very easy to 
perform and provide rapid results. Modifications of these tests allow the 
measurement of specific immunoglobulins (CampbelJ and Barton, 1988). 
Enzyme-linked immunosorbent assays which correlate well with the mouse test 
are available (Campbell and Barton, 1988; Grassi et al., 1989). 
Other methods for the detection of rabies antibodies include a plaque 
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neutralization test (Wiktor, 1973b ), complement fixation (Kuwert, 1973a), 
hemagglutination inhibition (Kuwert, 1973b ), passive hemagglutination (Dierks 
and Gough, 1973), gel immunoprecipitation (Lepine, 1973a), radioimmune assay 
(Wiktor, 1973a), indirect immunofluorescence (Johnson and Emmons, 1980), 
soluble antigen fluorescent antibody test (Garnam et al., 1977), and dot 
immunobinding (Heberling et al., 1987). Serologic tests are used primarily for 
assaying immune status in animals and people following vaccination, or for 
epidemiologic studies. Varying immune responses to natural infection limit the 
interpretation in potentially infected animals (Murphy, 1977). 
Epidemiology 
In spite of improved technology, rabies continues to spread in the world 
(Beran and Crowley, 1983). Jn 1988, with the exception of 60 countries, rabies 
was found worldwide (Baer et al., 1990). Throughout the world, rabies exjsts and 
is maintained as an infection in different principal hosts which also may act as the 
reservoir species (Beran, 1981). Two distinct epidemiological forms characterized 
as urban and sylvatic cycles are recognized (Steele, 1988). 
Jn the urban cycle, the dog is the principal vector for transmission to other 
animals (Acha and Arambulo, 1985, Beran, 1981). This is especially true in 
developing countries. Wild animals may be infected by dogs and then spread the 
disease to people, but they play only a minor role in the rabies cycle (Beran and 
Crowley, 1983). In most countries of the world, the incidence of human rabies 
closely parallels the incidence of disease in dogs. Almost all cases of human 
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rabies originate in countries with uncontrolled canine rabies (Baer et al., 1990). 
The true number of human rabies cases worldwide can only be estimated. Acha 
reported 20,482 confirmed human deaths in 1981 and over 500,000 persons 
receiving post-exposure rabies treatment (Acba and Arambulo, 1985). In India, 
China and Thailand, it is estimated that 45,200 to 57,300 people die of rabies 
each year and over 3 million people receive post-exposure treatment (Baer, 
1988b ). It is widely recognized that the number of rabies cases is grossly under 
reported (Baer, 1988b; Warrell and Warrell, 1988). 
Sylvatic rabies consists of two distinct groupings; terrestrial animal rabies 
and bat rabies. Bat rabies does not have geographically distinct outbreak areas 
and bat rabies exists as enzootics independent of the cycle in terrestrial animals 
(Smith, 1989). Wildlife species of the canidae family are the principle terrestrial 
reservoirs and distinct outbreak areas exist (Acha and Arambulo, 1985). Avian 
species can be experimentally infected with rabies, but birds are not hlghly 
susceptible and are of limited importance in the epidemiology of rabies (Shannon 
et al., 1988). The predominant reservoir species worldwide are as follows: (Acha 
and Arambulo. 1985; Everard and Everard, 1988; Kaplan, 1985; Jenkins et al., 
1988, Hubschle, 1988; Smith 1989; Pacer et al., 1985) 
Africa - kudo antelopes (Tragelaphus strepsiceros) 
- jackals (Canis mesomelas) 
- wolves (Canis lupus) 
- mongooses (Viverridae) 
- dogs (Canis familiaris) 
Asia - artic foxes (Alopex lagopus) 
- wolves (Canis lupus) 
- dogs (Canis familiaris) 
Central 
America 
Europe 
North 
America 
South 
America 
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- mongooses (Viverridae) 
- dogs (Canis f amiliaris) 
- red foxes (Vulpes vulpes) 
- raccoon dogs (Nyctereutes procyonoides) 
- skunks, primarily striped skunk (Mephitis m ephitis) and spotted 
skunk (Spilogali putorius) 
- raccoons (Procyon lotor) 
- red foxes (Vulpes vulpes) 
- artic foxes (Alopex lagopus) 
- grey foxes (Urocyon cineroargenteus) 
- vampire bats, primarily common vampire (Desmodus rotundus) 
- dogs (Canis f amiliaris) 
Various mechanisms are responsible for the maintenance and spread of 
rabies virus in nature (Martin and Sedmak, 1983). Epidemiologically the most 
important route of transmission is by bite wound and transfer of saliva. Although 
all warm blooded animals are able to become infected and spread the disease, 
the adaptability of a strain to a particular host is very important. Maintenance 
and spread depend largely on the ecology of the host species (Kaplan, 1985). 
Other factors affecting transmission are the variable incubation period of the 
virus and variability of secretion of virus in saliva. Uncommon occurrences not 
completely understood include subclinical infections with shedding, latent 
infections, and recovered healthy carriers (Baer, 1975a; Beran, 1981; Kaplan, 
1985; Martin and Sedmak, 1983). All of these assure maintenance of infection 
despite the usually fatal course of the disease. 
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Rabies in the United States 
Rabies in the United States has changed dramatically in the last 40 years 
(Beran, 1981; Pacer et al., 1985). With the advent and widespread use of 
effective domestic animal vaccines in the 1950s, dog rabies decreased dramatically 
from 8000 to 10,000 cases per year to less than 100 per year (Pacer et al., 1985). 
At the same time, wildlife rabies has been increasing (Baer et al., 1990; Smith, 
1989). In 1988, 4724 laboratory confirmed cases were reported in the United 
States and its territories (Centers for Disease Control, 1989). Of these, 4174 
(88.4%) were wildlife species (Centers for Disease Control, 1989) which is 
estimated to represent only one to ten percent of the actual incidence (Beran, 
1981). 
Laboratory confirmed cases in wildlife species are most common in the 
skunk, raccoon, fox and bat with skunks and raccoons accounting for the majority 
of the cases (Smith, 1989). In 1989, skunks accounted for 37.9% of the rabies in 
animals (Centers for Disease Control, 1989) whereas in 1953 skunk rabies was 
recognized in only 5 states and accounted for only 3.6% of the cases (National 
Communicable Disease Center, 1964 ). Since 1960, skunks have been the animal 
most frequently reported rabid in the United States (Centers for Disease Control, 
1977 and 1989). An epizootic of raccoon rabies in the Eastern United States has 
made this animal the second most common rabid wildlife species since 1982 
(Baer et al., 1990). In 1989, 31.1 % of the total wildlife cases were in raccoons 
(Centers for Disease Control, 1989). The increase in this species has been 
dramatic. Raccoon rabies was only sporadically diagnosed until it was recognized 
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in the southeast in the late 1940s (Kappus et al., 1970), and in the mid-Atlantic 
states in the 1970s (Jenkins et al., 1988). In contrast, fox rabies has been 
decreasing. In 1953, 1033 cases were reported and only 183 cases reported in 
1988 (Centers for Disease Control, 1989; National Communicable Disease Center, 
1964). Bat rabies has not changed much over the same time period. In 1988, 
bats accounted for only 0.14% of the total rabies versus 0.091 % in 1953 (National 
Communicable Disease Center, 1964; Centers for Disease Control, 1989). 
There are five geographical areas in the United States where antigenically 
distinct enzootic rabies occurs and all are in association with different wildlife 
species (Smith 1989). Within these areas, large numbers of rabies cases are 
reported in one major host species with only rare occurrence in other species 
(Smith, 1989). Monoclonal antibody studies directed against nucleocapsid 
proteins of rabies virus isolates have shown an ecotype species/geographical 
association (Smith et al., 1986). The skunk is the predominant reservoir host in a 
belt in the central United States from Minnesota to Texas and in northern 
California (Beran, 1981; Smith and Baer, 1988). Two distinct virus variants are 
observed in the northern and southern areas of this region (Smith et al., 1986). 
Striped skunks, and with less frequency spotted skunks, are the predominate 
species with hooded skunks and hog nose skunks seldom reported (Parker and 
Wilshack, 1966; Pacer et al., 1985). Raccoon rabies is found mainly in 
southeastern states and in middle eastern seaboard states of Maryland, Delaware, 
Virginia, Pennsylvania and West Virginia (Jenkins et aJ., 1988). Red fox rabies is 
seen in northern New York, grey fox rabies in areas of Texas and Arizona 
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(Kaplan, 1985). Bat rabies is reported in most states (Smith et al. 1986). Human 
rabies cases are sporadically reported, with only 12 cases reported within the last 
10 years, yet approximately 30,000 people receive post-exposure prophylactic 
treatment each year (Centers for Disease Control, 1989). 
Rabies in Iowa 
In Iowa, the skunk is the major reservoir and in 1989 accounted for 113 of 
203 total laboratory confirmed animal cases (Iowa Department of Public Health, 
1990). Of the other cases in 1989, 71 % occurred in cattle and cats because of 
spill-over into these species which are highly susceptible and not commonly 
vaccinated (World Health Organization, 1984). 
It is uncertain how skunks transmit virus among themselves and other 
species, but many factors are considered. Skunks occupy communal dens with 
single adult males in the winter; but in late winter, conflicts with wandering 
unattached males may allow for easy transmission and dispersal (Parker, 1975). 
High population density and turnover also help maintain the infection (Fernandes 
and Arambulo, 1985; Sargeant et al., 1982). Rabies infected skunks have been 
shown to travel widely (Storm and Verts, 1966). It is also common for adult 
males and juveniles to disperse over long distances (Hall, 1981). Highly variable 
incubation periods of 14 to 177 days in natural infections (Sikes, 1962), would 
allow for maintenance of the virus over winter denning periods (Parker, 1975). 
Skunks can shed large amounts of virus in their saliva and oral transmission has 
been reported which may allow for transmission in the dens (Parker, 1975). 
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Rabies in Raccoons 
The natural habitat of raccoons ranges from southern Canada to Panama, 
including all areas of the continental United States except high mountains and 
deserts (Kaufmann, 1982). Raccoons have been introduced in areas of the Soviet 
Union and are established in several European countries (McLean, 1975; Artois 
et al., 1989). Raccoons are considered to be highly intelligent and able to live in 
close association with people in both urban and rural areas, often thriving on 
human garbage (Hoffman and Gottshang, 1977). 
McLean reports that the first known case of rabies in raccoons was found in 
California in 1936 (McLean, 1975). Prior to 1950, there were only sporadic 
reports of rabies in raccoons across the United States (McLean, 1975). Since 
then, two epizootics of raccoon rabies have been recognized (Jenkins et al., 1988). 
The first epizootic started in Florida from a focus of one positive raccoon in 1947 
(Bigler et al., 1973). By 1959, the raccoon was the most commonly reported 
rabies host in that state (McLean, 1975). The disease extended northward 
through Florida and into the surrounding states of Georgia, Alabama and South 
Carolina at a rate of approximately 25 miles per year (Kappus et al., 1970; 
McLean, 1975). Before 1962, only 2 cases of rabies bad been reported in 
Georgia. In 1963, the number of cases of raccoon rabies in the United States 
increased to over 100 for the first time and the raccoon was identified as an 
emerging wildlife host (National Communicable Disease Center, 1964). Today all 
of Florida, most of Georgia and South Carolina and eastern Alabama are 
enzootic for raccoon rabies (Pacer et al., 1985). 
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In 1977, a similar epizootic occurred in the middle Atlantic states which has 
now extended into Delaware, Maryland, Pennsylvania, Virginia, West Virginia 
and the District of Columbia (Hubbard, 1985). Cases of rabies went from 
sporadic reports and one positive case in 1977 to 1608 cases in 1983 (Jenkins et 
al., 1988). The highest number of cases of rabies in raccoons in the United 
States occurred in 1983 when 1820 cases were reported (Centers for Disease 
Control, 1984). 
It is unknown why these regional epizootics occurred. In Florida, habitat 
destruction and decreased rainfall have been suggested as causative factors 
(Hubbard, 1985). Also, physiological stress due to overcrowding has been 
suggested (McLean, 1975). The mechanism for the mid-Atlantic outbreak is 
probably due to translocation of Florida raccoons to the area for restocking 
purposes (Smith et al., 1984). Monoclonal antibody studies have shown similar 
antigenic characteristics in rabies virus isolates from the two areas (Smith et al., 
1984). 
Control 
Throughout the world, rabies is maintained in enzootic areas because of the 
presence of reservoir animals (Beran and Crowley, 1983). From these animals, 
the disease is spread to other susceptible hosts including people (Kaplan, 1985; 
Martin and Sedmak, 1983). Effective control measures involve breaking the cycle 
of transmission between susceptible hosts (Steele, 1988). The strategy of breaking 
the cycle depends on many factors some of which include the reservoir population 
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distribution, density and ecology of the reservoir host, and providing protection to 
alternate hosts from exposure or infection (Beran, 1981; Kaplan, 1985). If we 
consider the goal of animal rabies control programs to be reduction of rabies in 
people, there are distinct areas where the transmission cycle can be broken. 
These include prevention or elimination of disease in animals, avoidance of 
exposure to rabid animals, pre-exposure and post-exposure prophylaxis including 
wound care, and active and passive immunization (Baer et al., 1990). Control 
programs aimed at human vaccination are not epidemiologically sound and are 
not the most economical way to control rabies. Therefore, control methods must 
be aimed at reducing animal rabies. 
Control programs in areas where dog rabies is dominant have included such 
methods as population reduction, restriction on animal movements, and mass 
vaccination programs (Beran and Frith, 1988). Dog control, vaccination programs 
and the removal of unrestricted animals offer the best method of canine rabies 
control (Beran and Frith, 1988; Middaugh and Ritter, 1982). 
Population reduction methods and mass vaccination programs have been the 
most widely used control programs for terrestrial wildlife species (Kaplan, 1985; 
Lewis, 1975). The aim of population reduction is to lower the reservoir host 
animal density to a point below the minimum threshold to allow rabies to 
maintain infection without eradicating the population (Baer, 1985; Kaplan, 1985; 
Sedmak and Martin, 1984 ). Methods that have proved successful include 
shooting, den gassing, trapping and poisoning (Lewis, 1975,; Rosatte et al., 1986). 
However, as with dog rabies control programs, population reduction methods 
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have had only limited success and do not offer permanent solutions due to animal 
migration (Baer, 1988b; Wilhelm and Schneider, 1990). Humane interests are 
also a factor in population reduction programs. 
Immunization programs aimed at wildlife were used as an alternate method 
of wildlife rabies control as early as 1962 (Baer, 1988b ). Although parenteral 
vaccination of wildlife is successful in the laboratory (Blancou et al., 1986), and in 
the field (Rosatte et al., 1990; Thiriart et al., 1985), widespread parenteral 
vaccination of wildlife is not practical and there is no licensed rabies vaccine 
available for such use in. wild animals in the United States. The first successful 
oral vaccination of wild animals in the laboratory occurred in foxes in 1971 with 
an attenuated vaccine (Baer et al., 1971). The first field trial using an oral 
vaccine was carried out in Switzerland in 1978 where the spread of the disease in 
foxes was controlled (Steck et al., 1982a, 1982b, Wandeler, 1988). Recent success 
in several countries with the use of attenuated modified live vaccines makes oral 
vaccination of wild animals and widespread control of wildlife rabies more 
feasible (Crick, 1985; Wandeler, 1988). Advances in genetically engineered 
vaccines also provide mechanisms for vaccinating wildlife. A live raccoon 
poxvirus vectored vaccine has proven successful in a number of species (Esposito, 
1989). A live vaccinia virus vectored vaccine with the raccoon and fox as the 
primary target species bas been found to be effective in laboratory experiments in 
numerous species (Rupprecht et al., 1988). This vaccine has been used in field 
tdals in Europe (Blancou et al., 1989; Wiktor et al., 1984), and the United States 
(Associated Press, 1990). A live adenovirus vectored vaccine is also reported 
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(Prevec et al., 1990). 
In addition to successful vaccination of the target species with these 
genetically engineered vaccines, vaccinated animals can be distinguished from 
naturally exposed animals because only the rabies virus glycoprotein gene has 
been inserted into the vector (Kieny et al., 1984 ). Other developments in the 
production of wildlife vaccines include the construction of an Escherichia coli 
plasmid that carries the glycoprotein gene (Yelverton et al., 1983), and possible 
synthetic vaccines (Koprowski, 1988). Anti-idiotypic antibodies have also been 
shown to induce neutralizing antibodies to rabies virus glycoprotein (Reagan et 
al., 1983). 
Control of insectivorous bat rabies may never be possible, however limiting 
roosting sites in populated areas and education of the public about the hazards of 
handling sick bats may be the best method of control (Linhart, 1975). Control of 
vampire bat rabies and subsequently of cattle rabies has been of limited success. 
Use of effective bovine vaccines and selective reduction of bat populations with 
the use of anticoagulant substances or fumigation of bat roosts has been 
employed (Linhart, 1975). 
In any control situation, ongoing reporting, surveillance and border 
protection are essential (Beran and Crowley, 1983; Steele, 1988). Ecological and 
social factors are of primary importance when considering a control program 
(Beran and Crowley, 1983; Fernandes and Arambulo, 1985). Public acceptance 
of any control program is critical and extensive education programs for health 
professionals and the public are needed (Beran, 1981). 
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SECTION I. SEROLOGIC SURVEY FOR RABIES SERUM 
NEUTRALIZING ANTIBODIES IN RACCOONS (PROCYON 
LOTOR) IN TWO COUNTIES IN IOWA 
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SUMMARY 
Between 1984 and 1988, a study was conducted to evaluate the nature and 
prevalence of rabies virus neutralizing antibodies in raccoons (Procyon lotor) in 
two counties in Iowa. A total of 985 raccoons were trapped and tagged in 
Guthrie and Cerro Gordo counties during the spring, summer and fall of each 
year. Blood samples from 1048 raccoons were collected. Sex, age and other 
parameters were recorded for each animal. Serum samples were tested for the 
presence of serum neutralizing antibodies (SNA) by the rapid fluorescent focus 
inhibition test (RFFIT), mouse serum neutralization test (MSN), and an indirect 
fluorescent antibody (IF A) technique for detecting immunoglobulin G. The study 
was designed to investigate the prevalence and nature of SNA in normal raccoons 
in these Iowa counties. Fifty-one raccoons (5.2%) were found to have SNA by 
the RFFIT. Thirty-six serum samples were also tested by the MSN, with results 
correlating well with the RFFIT results. Of 35 raccoons with measurable SNA, 
six individuals were found to be positive by IFA Jn contrast, 2 of 737 (0.27%) of 
raccoons submitted for rabies testing to the Iowa State University Veterinary 
Diagnostic Laboratory during the study period were found to be positive for 
rabies antigen. The disparity between the percentages of animals with SNA and 
those animals found to be positive by antigen detection tests, suggest that 
exposure to rabies virus in the wild is greater than indicated by the results from 
laboratory confirmed cases. 
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INTRODUCTION 
Two epizootics of raccoon rabies in the southeastern and mid-Atlantic areas 
of the United States have made the raccoon the second most commonly reported 
rabid wildlife species since 1982 (Baer et al., 1990). Reported cases of raccoon 
rabies in the United States increased from 62 cases in 1962, to 1820 cases in 1983 
(Centers for Disease Control, 1984; National Communicable Disease Center, 
1964). Although the number of cases dropped to 1463 in 1988 (Centers for 
Disease Control, 1989), areas considered to be enzootic for raccoon rabies have 
continued to enlarge outwardly from initial foci of infection (Jenkins et al., 1988). 
It is believed that the mid-Atlantic epizootic originated from transplanted 
raccoons from the southeastern epizootic (Smith et al., 1984 ). Presently, the 
majority of rabies cases in raccoons in the United States are limited to these two 
enzootic areas. In 1988, raccoons from these areas accounted for 99.4% of all 
cases of raccoons rabies in the United States (Centers for Disease Control, 1989). 
Outside of raccoon rabies enzootic areas, raccoons are believed to be alternate 
hosts and not involved in the transmission and maintenance of the disease in 
wildlife (Smith et al., 1986). 
Serologic investigations of the prevalence of serum neutralizing antibodies 
(SNA) in raccoons have shown that the prevalence is much greater than the point 
prevalence of the disease based on data from diagnostic laboratories (McLean, 
1975). Studies on sera collected outside of epizootic areas in Alabama, Texas, 
Tennessee, Illinois, and South Carolina have shown seropositive rates ranging 
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from 0-5.6% (McLean, 1975). Seropositive prevalence rates of 3-12% have been 
reported in counties bordering an epizootic in Florida 130 miles from the front 
(McLean, 1975). In contrast, other serologic studies in non-enzootic areas have 
demonstrated no evidence of rabies; no detectable SNA was reported in Virginia 
in 1982 on the border of an epizootic area and 100 miles distant (Carey and 
McLean, 1978), nor in the Great Smoky Mountains in 1979 and 1980 (Rabinowitz 
and Potgeiter, 1984). 
Within areas with enzootic raccoon rabies, or following epizootics, 
seropositive prevalence rates in raccoons range from 7.2% (McLean, 1975) to 
28% (Bigler, 1973). Point prevalence as high as 35% has been reported 
(McLean, 1975). Serologic studies during the mid-Atlantic epizootic have shown 
prevalence rates of 14.26% to 18.56% (Centers for Disease Control, 1983 and 
1985). 
With this evidence, many researchers have concluded that many raccoons 
develop subclinical forms of rabies (Bigler et al., 1983; Doege and Northrup, 
1974; McLean, 1975). There is limited evidence of rare inapparent infection from 
field and laboratory studies in America, Africa, Asia and Europe (Doege and 
Northrup, 1974). There is serologic evidence of infection without clinical disease 
in laboratory experiments in normal foxes, skunks and dogs (Bell, 1975; Parker 
and Wilsnack, 1966; Sikes, 1962). 
The presence of SNA in such studies is difficult to interpret because the 
type of antibody test is not always reported, actual titer may not be reported, and 
differing levels of classification of positive animals cloud the interpretation. In 
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some studies, animals with serum neutralizing (SN) antibody titer < 8.0 (Rosatte 
et al., 1990), or <25.0 (Jenkins et al., 1988) were considered negative. 
In addition to the lack of agreement on the threshold value, there are 
reports of low level false positive SN antibody titers in raccoon sera when using 
fluorescent antibody based cell culture virus inhibition tests (Barton and 
Campbell, 1988). Cell cytotoxic factors in the serum have been suggested as the 
cause (Barton and Campbell, 1988). 
The true reason for the prevalence of low level SN antibody titer bas yet to 
be determined. Possibilities include previous exposure to nonfatal infection or a 
latent state of disease as evidenced by terms such as "abortive disease", 
"inapparent infection", "subclinical carriers", "asymptomatic carriers", "normal 
survivor" and "survivor with sequelae" which are found throughout the literature 
(Doege and Northrup, 1974). Other possibilities for the presence of low level 
rabies-specific SNA in addition to previous exposure to a sub-lethal virus include 
non-specific virus neutralizing reactions, current rabies infection, or previous 
vaccination and release. 
Rabies has only been sporadically reported in raccoons in Iowa. OnJy 70 
confirmed cases have been reported since 1950 (Iowa Department of Public 
Health, 1951-1989). In contrast, evidence from a serologic survey in Iowa in 1971 
and 1972 indicates that 7.6% of the raccoons had SNA (Niemeyer, 1973). This 
information, along with serologic reports of SNA in other areas of the country 
without enzootic raccoon rabies, raises questions about the disease in raccoons in 
areas without enzootic raccoon rabies. 
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The purpose of this study was to investigate the prevalence and nature of 
SNA in normal raccoons in two counties in Iowa and factors associated with 
seropositive rates, and compare these data with confirmed positive cases. 
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MATERIALS AND METHODS 
Epidemiologic Analysis of Confirmed Rabies Cases 
Data of retrospective epidemiological analysis investigating the number of 
rabies cases in raccoons were collected from Iowa Annual Rabies Summaries 
(Iowa Department of Public Health, 1950-1989) and from rabies submission 
summaries from the Iowa State University Veterinary Diagnostic Laboratory. 
Animals 
Guthrie County raccoons were trapped over the five year period of 1984-
1988 by the Department of Animal Ecology, Iowa State University, Ames, Iowa. 
Trapping occurred in two ten week periods starting in March and August. Blood 
samples we re collected and the an imal's sex, weight and field age were recorded. 
Ages were determined by tooth extraction, sectioning and cementum annuli 
analysis. Cerro Gordo County raccoons were trapped over a five month period 
(March-July) during each of the years 1984-1988 by the Iowa Department of 
Natural Resources. Samples and data were collected similar to that for Guthrie 
County. Serum samples were also collected from farm raised raccoons1• All sera 
were heat inactivated (56° C for 30 minutes) and kaolin treated with a 25% kaolin 
preparation fo r 30 minutes to absorb non-specific inhibitors. Serum samples were 
stored frozen (-20° C) until tested. 
1Ruby's Fu r Farm, New Sharon, IA 50207. 
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Serum Neutralizing Antibody Titer Determination 
Sera were analyzed by the rapid fluorescent focus inhibition test (RFFIT) 
(Smith et al., 1973) and the mouse serum neutralization (MSN) test (Atanasiu, 
1973) for the presence of antibodies against rabies virus. Serial two-fold dilutions 
were made and titer expressed as reciprocal of the highest dilution capable of 
reducing the number of rabies infected baby hamster kidney (BHK) cells by 50%, 
or producing 50% mortality in mice as determined by the Reed-Muench method 
(Reed and Muench, 1938). Test controls for the RFFIT included uninfected cell 
controls, back titration of rabies virus challenge dose, negative antirabies sera and 
titration of positive raccoon antirabies sera. Sera were tested in BHK-21(C-13) 
cells2 using the Challenge Virus Standard (CVS-11) virus3• Test controls for the 
MSN test included positive and negative raccoon antirabies sera and 25-50 mouse 
intracerebral lethal dose50 (MICLD50) of a CVS rabies virus
4
• Five 13-15 gram 
female mice5 per serum dilution were used. Ten mice per dilution were used for 
the challenge titration. 
2Cells originated from the Centers for Disease Control and were supplied to our 
laboratory by the National Veterinary Services Laboratories, Ames, IA 50013. 
3Rabies virus from the Centers for Disease Control, Atlanta, GA 30333. 
4Rabies virus provided by the National Veterinary Services Laboratories, 
Ames, IA 50013. 
5
Sprague Dawley CF-1 mice, Harlan Sprague Dawley, Inc., Indianapolis, IN 
46229. 
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Indirect Fluorescent Antibody Determination 
An indirect fluorescent antibody (IFA) test was performed using an 
adaptation of a previously described test (Johnson and Emmons, 1980). One-
tenth milliliter of a dilution of Street Alabama Dufferin (SAD) virus4 was added 
to 0.4 milliliters of a cell suspension of Madin Darby canine kidney (MDCK) 
cells6 in eight chamber Lab-Tek cell culture slides7• Slides were incubated (37° 
C) in a humid chamber with 3-5% C02• After 72 hours, the supernatant was 
removed and the cells fixed with acetone (4° C) for 10 minutes, air dried and 
stored frozen until use. The cell sheet consisted of approximately 30% rabies 
infected cells. Following a phosphate buffered saline (PBS) rinse, 50 microliters 
of each dilution of raccoon sera were added to each chamber and incubated (37° 
C) for 30 minutes in a humid chamber. Slides were washed for 10 minutes in 
PBS. Each well was filled with 50 microliters of fluorescein isothiocyanate 
conjugated goat origin antiraccoon immunoglobulin G 8 and incubated (37° C) for 
30 minutes. Positive cell control wells were incubated with fluorescein 
isothiocyanate conjugated equine or bovine origin antirabies globulin9• Following 
a 10 minute wash in PBS, the slides were covered with a 50/50 (V /Y) glycerine-
6Cells originated from the ATCC and were supplied to our laboratory by the 
Na tional Veterinary Services Laboratories, Ames, IA 50013. 
7Miles Scientific, Division of Miles Laboratories, Inc., Naperville, IL 60566. 
8Kirkegaard and Perry Laboratories, Inc., 2 Cessna Court, Gaithersburg, MD 
20879. 
9BBL Microbiology Systems, Becton Dickinson and Co., Cockeysville, MD 
21030. 
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saline solution, overlaid with coverslips and examined with a fluorescent 
microscope. Titer is expressed as the reciprocal of the highest serum dilution still 
exhibiting specific fluorescence. Test controls included uninfected and infected 
cell controls, negative antirabies sera from farm raised raccoons (RFFIT antibody 
titer <4.0), and positive antirabies sera (RFFIT antibody titer of 8.0 and 160.0) 
from raccoons vaccinated with a killed virus vaccine10• Optimal dilutions of the 
reagents were previously determined by checkerboard titration. Presence of non-
specific fluorescence prevented serum dilutions of less than 1:10 from being 
tested. 
Analysis of Data 
Data were categorized into tables and graphs to study the effects of the 
factors such as season, sex and age on presence of SNA in the population. 
Statistical analysis was performed by comparison of proportions of two 
independent samples or the Chi-Square test (Snedecor and Cochran, 1989). 
1°Rabguard-TC, Norden Laboratories, Lincoln, NE 68501. 
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RESULTS 
Retrospective Analysis of Confirmed Rabies Cases 
Only 70 confirmed cases of rabies have been reported in raccoons in Iowa 
since 1950 (Iowa Department of Public Health, 1951-1989). Locations of 
confirmed cases in the state are shown in Figure 1. In Iowa, there were 939 cases 
of animal rabies confirmed during the study period from a total of 9388 suitable 
animals of all species submitted for testing. In 1987 the number of cases was 
significantly higher (P < .01) than previous years and 1987 was the peak year for 
confirmed rabies cases. The striped skunk (Mephitis mephitis) is the principle 
reservoir and accounted for 57.7% of the total number of cases and 97.5% of the 
reported cases in terrestrial wildlife between 1984 and 1988. Domestic animals 
accounted for 35.7% of the cases, bats accounted for 5.1 %, and other wildlife 
species accounted for 1.5%. Reported cases by year are shown in Table 1. The 
relationship between reported skunk cases and the reported cases in domestic 
animals is well described and is shown in Figure 2. 
In Guthrie County, 115 animals of all species were tested during the study 
period and 8 (7.0%) were found positive. In Cerro Gordo County, 150 animals 
were tested with 15 (10.0%) positive. The peak year for laboratory confirmed 
rabies in both counties was also 1987 (Table 2). Year by year positive prevalence 
rates for these two counties echoed the statewide prevalence rate. 
Statewide, the majority of the positive cases were due to skunks which had 
an overall test positive rate of 79.0%. Year by year testing and positive rates are 
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Figure 1. Number of laboratory confirmed cases of rabies in raccoons in Iowa counties for the years 1951-1989 
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Table 1. Reported cases of rabies in skunks, domestic animals, bats, and wildlife 
in Iowa for the years 1984-1988 
Domestic Other 
Year Skunks Animals Bats Wildlife Total 
1984 91 50 8 1 150 
1985 95 37 17 1 150 
1986 99 84 6 2 192 
1987 161'' 90 12 8 272" 
1988 96" 74 5 0 175" 
Total 542 335 48 12 939 
Percent 57.7 35.7 5.1 1.5 
* * Significantly different (P < .01) from the previous year. 
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animals in Iowa for the years 1954-1989 
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Table 2. Reported number of animals tested for rabies in Cerro Gordo and 
Guthrie Counties for the years 1984-1988 
Cerro Gordo County Guthrie County 
Percent Percent 
Year Examined Positive Positive Examined Positive Positive 
1984 31 2 6.5 22 2 2.1 
1985 29 2 6.9 19 0 0.0 
1986 26 3 11.6 23 1 4.3 
1987 37 7 18.9 28 4 14.3 
1988 27 1 3.7 23 1 4.3 
Total 150 15 10.0 115 8 7.0 
Table 3. Reported number of skunks, raccoons and all animals tested for rabies in Iowa for the years 1984-1988 
Skunk Raccoon Total All Species 
Percent Percent 
Year Examined Positive Positive Examined Positive Examined Positive Positive 
1984 143 91 63.6 146 0 1849 150 8.1 
1985 109 95 87.2 163 0 1886 150 8.0 
1986 144 99 68.8 188 1 1944 192 9.9 
~ 
V1 
1987 189 161 85.2 113 1 1978 272 13.9 
1988 101 96 95.0 127 0 1731 175 10.1 
Total 686 542 79.0 739 2 9388 939 10.0 
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shown in Table 3. 
Two cases of rabies in raccoons were reported in the state between 1984 
and 1988, from a total of 737 raccoons (0.27%) submitted for testing. In each 
year except 1987, more raccoons were submitted for testing than skunks. No 
confirmed cases of rabies in raccoons were found in either of the two counties 
involved in the study during the sampling period. 
Characteristics of Raccoon Samples 
Guthrie County 
A total of 951 blood samples were collected from 891 wild trapped raccoons 
during two ten week trapping periods in the spring/early summer and late 
summer/fall of 1984 through 1988. Fifty-two animals were sampled more than 
once, eight of which were re-trapped in the same season of the same year. The 
number of samples collected each year were statistically balanced (P < .05). Table 
4 shows that with the exception of 1984, the majority of the samples were 
collected during the second ten week trapping period. Distribution of samples by 
age group were similar; 53% were from adults and 47% from juveniles less than 
one year old. The majority of the juveniles (96.9%) were collected during the 
second trapping. The sex distribution of animals trapped over the 5 year period 
was 54.3% male and 45.7% female. A larger percentage of the males (37.8%) 
were trapped during the spring than females (30%). The distribution of age 
groups within sexes was similar. Table 5 shows the number of samples collected 
in each sex and age category by year. 
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Table 4. Number of raccoons trapped in Guthrie County during the years 
1984-1988 
First Trapping Second Trapping Percent 
Year March - July August - October Total By Year 
1984 90 91 181 19.0 
1985 76 136 212 22.3 
1986 70 122 192 20.2 
1987 53 154 207 21.8 
1988 37 122 159 16.7 
Total 326 625 951 100.0 
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Table 5. Number of raccoon serum samples collected in Guthrie County for the 
years 1984-1988 
Male Female 
Year• Adult Juvenile Adult Juvenile 
1984 80 27 46 28 
1985 50 62 53 57 
1986 59 45 54 34 
1987 57 51 46 53 
1988 42 43 27 47 
Total By 
Age Group 288 228 216 219 
Total 
By Sex 516 435 
"Includes 8 animals trapped more than once in a season and 12 animals 
trapped more than once in a year. 
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Cerro Gordo County 
A total of 97 blood samples were collected from 94 wild trapped raccoons 
during a five month collection period (March-July) for the years 1984-1988. 
Three raccoons were sampled twice. Sample size on a yearly basis ranged from a 
low of 12 in 1984 to 28 in 1985. The largest number of collections were in May 
and June with 32.0% and 24.7% of the samples collected during these months. 
All of the raccoons sampled were adults and the majority (69.1 %) were male 
(Table 6). 
Serum neutralizing antibody analysis 
Sera from 1048 wild trapped raccoons were tested by the RFFIT test for 
SNA. Fifty-one of 985 raccoons (5.2%) had SN antibody titer >3.0. Titer ranged 
from 3.2 to 24.2. Sera from 30 farm raised raccoons were tested and none had 
measurable SN antibody titer. 
In order to confirm the results of the RFFTT test, 36 samples (24 with 
RFFIT antibody titer > 3.0, and 12 <3.0) were subjected to the MSN test and 
correlation analysis. Twenty-three samples were positive by the MSN test with 
titer ranging from 3.2 to 17.9 (Table 7). The RFFIT test identified one more 
positive than the MSN test. Results from the two tests were well correlated 
(r = 0.86, P < .01). Regression analysis shows that overall the RFFTT titer was 1.28 
times that of the MSN (Figure 3). 
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Table 6. Number of raccoons trapped in Cerro Gordo County for the years 
1984-1988 
Percent 
Year Male Female Total By Year 
1984 10 2 12 12.4 
1985 21· 7 28 28.9 
1986 12 5 17 17.5 
1987 10 7 17 17.5 
1988 14 9 23 23.7 
Total 67 30 97 
Percent 69.1 30.9 
·one animal trapped twice in 1985. 
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Table 7. Correlation of rapid fluorescent focus inhibition test (RFFIT) antibody 
titer and mouse serum neutralization (MSN) test antibody titer 
determinations 
RFFIT Antibody Titer 
MSN 
Antibody Titer <3.0 >3.0 Total 
<3 .0 12 1· 13 
>3.0 0 23 23 
Total 12 24 36 
"RFFIT antibody titer of 4.8. 
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Figure 3. Correlation plot between rapid fluorescent focus inhibition test 
(RFFIT) and mouse serum neutralization (MSN) test antibody 
determinations for the sera shown in Table 7 
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Guthrie County 
Forty-eight of 891 animals had SN antibody titer >3.0 by the RFFIT, 
representing an overall prevalence rate of 5.4%. Of the 52 animals which were 
sampled more than once, 47 animals with no measurable SNA were re-trapped 
multiple times, 1 had SN antibody titer > 3.0 on trapping dates 6/10/ 87 and 
9/ 27 / 87, and 4 animals had SNA in the final sample collected. 
Prevalence rates varied among the years, seasons, sexes and age groups. 
Prevalence rates by year were 4.4% in 1984, 2.1 % in 1985, 1.6% in 1986, 9.7% in 
1987 and 6.9% in 1988. The rate in 1987 was significantly higher (P < .01) than 
the previous years. Correlation between these prevalence rates and the number 
of skunk cases in the state is shown in Figure 4. 
On a seasonal basis, significantly more (P < .01) of the samples from the first 
trapping period had measurable SNA (8.3%) than from the second trapping 
period (3.6%) (Table 8). The rate of measurable SNA was significantly higher 
(P < .01 ), among adults (7.8%) as compared to juveniles (2.3% ). All positive 
juveniles were found during the fall. The prevalence rates were similar among 
males (5.4%) and females (4.9%). When comparing prevalence rates among 
season and sex groups for adults, adult males trapped during the spring/ early 
summer trapping showed the highest prevalence rate (9.8%), with adult males 
sampled during the late summer / fall showing the lowest rate (3.8%) (Table 8). 
Seasonal rates among adults were not significantly different. 
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Figure 4. Correlation between laboratory confirmed cases of rabies in skunks in 
Iowa and serum neutralizing antibody titer as determined by the rapid 
fluorescent focus inhibition test (RFFIT) in raccoons in Guthrie County 
for the years 1984-1988 
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Table 8. Percentage of Guthrie County raccoons with serum neutralization 
antibody titer > 3.0 as determined by the rapid fluorescent focus 
inhibition test (RFFIT) for the years 1984-1988 
Trapping 
Period" 
March-
Male 
Adult 
Female 
Juvenile 
Male Female Total 
July 9.8 (18/183t 7.1 (9/127) 0.0 (0/11) 0.0 (0/3) 8.3 (27 /324)"' 
August-
October 3.8 (4/103) 9.3 (8/86) 2.8 (6/217) 1.9 (4/213) 3.6 (22/619) 
Total 
By Sex 7.7 (22/286) 8.0 (17 /213) 2.6 (6/228) 1.9 (4/216) 
Total 
By Age 
Group 
7.8 (39/499)" 2.3 (10/444) 
'Eight animals trapped more that once in the same season are not included in 
these data. 
bNumber of animals in each category shown in parenthesis. 
**Significantly different (P<.01) from corresponding trapping or age group 
category. 
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Cerro Gordo County 
Three of 94 raccoon samples had SN antibody titer > 3.0 by the RFFIT, 
representing an overall prevalence rate of 3.2%. Three animals with no 
measurable SNA were sampled more than once. The three samples with SNA 
came from two adult males trapped in June, 1988 and from one adult female 
trapped in April, 1986. 
Indirect fluorescent antibody analysis 
Sera from 81 wild trapped raccoons from both counties were tested by the 
IF A test (35 with RFFIT antibody titer > 3.0, and 46 < 3.0). Insufficient amounts 
of sera prevented all of those with RFFIT antibody titer from being tested by the 
IFA None of the sera with RFFIT antibody titer < 3.0 were positive by the IFA 
test. Six animals were positive for antirabies immunoglobulin G by the IFA test 
at the 1:10 dilution and three of these at the 1:25 dilution. All of the positive 
samples were from adult raccoons in Guthrie County. Sex, seasonal distribution, 
and RFFIT and MSN antibody titers of those animals positive by the IF A test are 
shown in Table 9. 
In an attempt to determine the sensitivity of the IFA test, 11 sequential 
serum samples (RFFIT antibody titer > 3.0) from vaccinated raccoons and 
raccoons experimentally infected with skunk virus, and 20 sera from farm raised 
raccoons (RFFIT antibody titer < 3.0) were subject to the IFA test and 
correlation analysis. 
Samples with RFFIT antibody titer < 3.0 were negative by the IFA test at 
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Table 9. Guthrie County raccoons with rabies-specific imrnunoglobulin G as 
detected by an indirect fluorescent antibody (IFA) technique 
Trapping Age in Weight RFFIT" MSN1' 
Date Sex Years in kg. Titer Titer IFAC 
08/ 18/84 M 1 6.8 4.3 NDd Positive 
05/30/87 M 1 5.9 10.8 5.3 Positive 
06/07/87 M 3 7.2 5.3 5.2 Positive 
08/31/87 F 1 5.4 13.3 6.0 Positive 
09/10/87 F 4 6.8 6.4 ND Positive 
05/07/88 M 2 6.1 17.6 ND Positive 
'Antibody titer as determined by the rapid fluorescent focus inhibition test. 
bAntibody titer as determined by the mouse serum neutralization test. 
clndirect fluorescent antibody results at serum dilution of 1:10. 
dND=Not done. 
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and indirect fluorescent antibody (IFA) antibody titers in sera of 
raccoons with known exposure to rabies antigen. Samples are paired 
by increasing order of RFFIT antibody titers 
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the 1:10 dilution. Samples with measurable RFFIT antibody titer were positive 
by the IFA test. Results of the two tests were correlated (r=0.76, P <.01). 
Regression analysis comparing the IF A titer to the RFFIT titer demonstrates 
that the relative IF A titer changes as the RFFIT titer increases. At low level 
RFFIT titer ( <40.0, 101.6), the IFA titer is higher and at higher RFFIT antibody 
titer the IF A titer is lower as shown in Figure 5. 
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DISCUSSION 
Even though clinical rabies in raccoons is uncommon in the central United 
States, it is important to understand the ro1e of the raccoon in areas where skunk 
rabies is enzootic in order to fully evaluate the public health importance of 
exposure to raccoons. Before the 1950s, rabies in raccoons was only sporadically 
reported in the United States. Epizootics in the southeast and mid-Atlantic 
regions over the last 40 years are indicative of an expansion of the raccoon 
adapted variant virus and the disease is continuing to expand outwardly from the 
enzootic centers (Centers for Disease Control, 1985; Jenkins et al., 1988). Should 
raccoon rabies ever become enzootic in areas with rabies in other species, the 
entire transmission/exposure cycle would become complicated. It is possible that 
raccoon rabies could expand across the whole country, or new epizootics could 
develop. Therefore, a basic understanding of the existing prevalence in non-
enzootic areas is critical. 
Since the early 1960s, Iowa has consistently been among the states reporting 
the highest total number of rabies cases yearly in the continental United States 
(Centers for Disease Control, 1977, 1987, 1988 and 1989). In Iowa, the sylvatic 
cycle of transmission of rabies is maintained in wild animals (Beran, 1981; Pacer 
et al., 1985). Although rabies is diagnosed in many species of animals in Iowa 
each year, striped skunks have dominated the total number of reported cases 
since 1953 and are considered the primary reservoir (Beran, 1981; Iowa 
Department of Public Health, 1953-1989). Recent studies usi ng monoclonal 
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antibodies have shown that only the skunk and bat variants have been identified 
in Iowa (Smith et al., 1986). Dog variants were probably present until widespread 
use of domestic animal vaccines after World War lI significantly reduced the 
number of dog cases in the United States (Pacer et al., 1985). 
This retrospective study on the specimens submitted to the Veterinary 
Diagnostic Laboratory for rabies examination helps confirm the role of the skunk 
as primary reservoir host in this state. When compared to all other species, the 
rate of rabies positive skunks per number of samples submitted (79.0%), is 
significantly higher (P < .01) than for any other species. Cases in other species are 
the result of spill-over from the primary host. Numbers of cases in other animals 
parallels numbers of cases in skunks. Total number of cases in the state were not 
significantly different from 1984 to 1986, but did increase significantly (P < .05) in 
1987. A similar trend was seen in the two study counties, demonstrating that on 
a smaller scale, these two counties are representative of the occurrence of rabies 
in the state. The increase in 1987 was expected because of the 7-9 year cyclical 
nature of rabies in the state. The small percentage (0.27%) of confirmed cases of 
rabies in raccoons in the state during the study period provides evidence that 
rabies is not maintained in raccoons. 
The distribution of animals trapped during this study is consistent with 
previous studies involving the trapping of raccoons in the wild (Bigler et al., 1973; 
Hubbard, 1985), indicating this sample correlates with other random trapping 
surveys. Sampling of more males than females was observed in both of the study 
counties. Increased trapping of juveniles occurred during the fall trapping and is 
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expected as young raccoons begin to leave the family unit and enter the general 
population. 
Prevalence rates for animals with SNA in this population varied among age 
groups, season and year. There were no significant differences between the sexes, 
adult age categories, or between weight group categories. This is to be expected 
because adult animals in the population should have equal chances of exposure to 
the virus. 
Distribution of positive animals varied among the adults and juveniles; there 
were significantly more adults than juveniles with SNA. This is consistent with 
length of time in the population being correlated with risk of exposure. 
The limited time frame for sample collection in this study does not allow 
detailed seasonal analysis. The significant decrease in prevalence rates from the 
spring to the fall trapping coincided with the large number of negative juveniles 
entering the population during the second trapping period. In raccoon rabies 
enzootic areas it is believed that rises in prevalence of SNA in the spring and fall 
are associated with animal contact during breeding activities and movements prior 
to the winter denning period. 
There was a significant rise in the prevalence rate in raccoons in 1987. This 
increase is correlated with the significant increase in the number of confirmed 
laboratory cases in the skunk in the state and the total number of cases occurring 
in each county during that year. Although the number of skunk cases dropped 
significantly the following year, the prevalence rate for positive raccoons by the 
SN test was not significantly different. Seropositive raccoons in 1988 were equally 
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balanced between the sexes and were higher in adults. Persistence of SNA in 
animals exposed the previous year may account for the rate remaining high. The 
one animal that was re-trapped and remained positive 109 days after the first 
positive sample provides evidence for the extended survival of animals with SNA 
in the wild. Previous studies have shown that re-trapped wild raccoons in 
enzootic areas can maintain SNA for 37 months (Bigler et al., 1983). Since these 
were wild animals, exposure or re-exposure to the virus is uncertain. 
Conclusions about the prevalence rate of SNA in this study come mainly 
from the Guthrie County data because of the larger sample size. Prevalence 
rates for Guthrie County (5.4%) and Cerro Gordo County (3.2%), were not 
significantly different (P < .01). Therefore, results from Guthrie County could be 
extrapolated to Cerro Gordo County. 
We must be cautious however in interpreting too much from a population 
with such low levels of SNA. There are other possibilities for virus neutralizing 
ability of sera from wild trapped raccoons. It is possible that antibodies directed 
against an agent other than rabies virus were the cause of the inhibition. Perhaps 
another rhabdovirus shares nucleoprotein antigens which cross react with the 
rabies virus in the test systems. The possibility exists of positive animals having 
been previously vaccinated and released into the wild. It is also possible that 
some factor in the sera was causing non-specific neutralization and the samples 
were falsely positive. There is little published information concerning non-
specific SNA in wildlife, yet many studies exclude animals with low level SNA as 
falsely positive. 
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In this study, three different tests were used to assess rabies antibody activity 
in the wild trapped raccoons. The RFFIT and MSN tests are based on the 
measurement of the ability of factors in the serum to inhibit the growth of 
challenge virus in cell cultures as detected by fluorescent antibody staining or the 
pathogenesis of the virus in mice. The mouse test has been the accepted 
standard for comparing other antibody detection tests. It is well reported that the 
neutralizing ability of serum samples is due to the presence of virus-specific 
neutralizing antibodies. 
There is little evidence of false positive reactions with the MSN test. There 
are reports of false positive levels of 0.8% in studies with pre-vaccination and 
post-vaccination sera from people (Larsh, 1965; Thomas et al., 1963). 
Considering the past performance of the MSN test, the most likely conclusion is 
that the SN antibody titers observed in this study represent specific virus 
neutralizing activity. 
Statistical analysis of the data from this study indicates that the RFFIT and 
MSN tests correlate well. The RFFIT antibody titer was on the average 1.28 
times higher that the MSN antibody titer and identified one more positive than 
the MSN test. The RFFIT test has been shown to be less specific than the MSN 
test (Smith et al., 1973). Correlation between the RFFIT and MSN tests in this 
study provides evidence that lack of specificity in the RFFIT test was no different 
than previously reported. 
The third test was the IPA technique to detect irnmunoglobulin G. Using 
the results from known samples, there was good accord between the IF A and the 
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RFFIT test in recognizing positive and negative reactors. The results of the 
positive IF A tests in the wild trapped raccoons help to confirm that exposure to 
rabies antigen was occurring in the sample area. The number of positive samples 
by the IF A is too small to support detailed analysis of prevalence rates among 
different years, seasons, sexes, or age groups, but it is important to note that four 
of the six positive samples were from raccoons trapped in 1987, the peak year for 
rabies in each county and the state, and that no animals which were positive by 
the IF A test were negative by the RFFIT or MSN test. 
Although the overall correlation between the two tests in known sera with 
rabies-specific RFFIT antibody titer is good, at low level SN antibody titer ( < 40), 
the IF A titer was usually higher than the RFFIT titer and at higher SN antibody 
titer the IFA titer was usually lower. This indicates that the IFA is more 
sensitive in sera with low antibody titer. Similar differences in sensitivity as SN 
antibody titer changes have been reported (Grandien and Espmark, 1975). 
The IF A test measures antibody binding rather than specific virus 
neutralizing antibody. The RFFIT and IF A tests do not measure identical 
spectrum of antibodies; the binding in the IF A test is with the nucleocapsid 
rather than with glycoprotein as in the RFFIT (Campbell and Barton, 1988). 
Discrepancies between fluorescent antibody based tests and other antigen.-
antibody binding tests in sera with low level SNA have been reported (Barton 
and Campbell, 1988). Technical difficulties could also account for differences. 
Extra washing steps in the IFA test could disassociate antibodies with low affinity. 
Non-specific fluorescence at low serum dilutions does not allow titration of 
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sera by this IFA technique at less than the 1:10 dilution. This prevents direct 
comparison between the IF A and SN based tests in samples with low level titer. 
All of the wild trapped animals had SN antibody titer <25, and the majority of 
the samples had an antibody titer < 10 by both the RFFIT and MSN tests. 
Inconsistent results or poor correlation of the IF A test with the MSN test bas 
been reported (Grandien, 1977, Grandien and Espmark, 1975; Thomas et al., 
1963), as has false negative rates 14.3% in sera with low level SN antibody titer 
(Peck, 1966). 
Another possibility is that samples positive by the SN antibody based tests, 
but negative by the IFA, could be due to another class of antibody. If animals 
had been recently exposed to rabies, and only immunoglobulin M was present in 
the sera, the IFA test would be negative. The time period that this would occur 
would be limited to a few days, making it unlikely that many animals would have 
been sampled during this period. 
The need for further evaluation of the IF A test is demonstrated, yet the IF A 
positive results help to confirm that animals with SNA have been exposed to 
rabies antigen. 
If positive antibody titer represent post-exposure response, then questions 
exist as to whether the animals were in the process of developing clinical rabies, 
or were exposed and experiencing inapparent infection and halted progression of 
the disease. There is evidence of inapparent infection in raccoons in 
experimental challenge studies with a skunk rabies isolate (Section II. of this 
thesis). Raccoons developed rabies-specific SNA without dying when given 63,200 
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mouse intracranial lethal doseso (MICLDso) intramuscularly, suggesting that 
inapparent infections do occur. Further studies are needed to determine if the 
animals in the wild which are positive by serologic tests, had subclinical non-fatal 
rabies infections, had recovered from clinical disease, or were destined to die of 
clinical rabies. 
It appears from this study that there can be small numbers of raccoons with 
SNA in the wild in areas without enzootic raccoon rabies. Many of these animals 
have very low titer. Also, the number of animals statewide confirmed as rabies 
positive in the laboratory do not reflect the number of animals in the wild with 
SNA. Previous reports of the prevalence of SNA in raccoons has raised questions 
about rabies in raccoons in non-enzootic raccoon rabies areas. This study 
suggests that these questions are valid. The results of these tests demonstrate we 
must be cautious in the interpretation of serologic studies in wildlife and 
extrapolating from these data to make definitive statements about the prevalence 
of the disease in wildlife species. The RFFIT, MSN and IF A tests demonstrate 
that exclusion of all animals in serologic studies with titer less than a certain level 
is not justified. Such information could be helpful in the interpretation of 
seropositive prevalence rates in future serologic surveys. In addition, specific 
conclusions can be drawn from this study: 1) If those animals with SNA truly 
represent animals previously exposed to rabies virus, then it appears that a 
percentage of the raccoons in these counties are able to thrive and appear 
clinically normal after exposure. 2) With such a small percentage of raccoons 
having SNA, the raccoon does not play a significant role in the epidemiology of 
68 
the disease in these counties. 3) A minimum of 17% of the sampled animals with 
low level SN antibody titer ( <25.0) were shown to have rabies-specific 
immunoglobulin G. 4) If an e_nzootic of raccoon rabies entered these counties, 
the immune status of so few raccoons would not affect the occurrence of an 
epizootic of raccoon rabies. 
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SECTION II. EXPERIMENT AL INFECTION OF RACCOONS (PROCYON 
LOTOR) WITH RABIES VIRUS OF SKUNK ORIGIN 
75 
SUMMARY 
To determine raccoon (Procyon lotor) susceptibility and serum neutralizing 
antibody response to a skunk salivary gland rabies virus, nine raccoons were 
inoculated with a rabies virus isolated from a naturally infected Iowa striped 
skunk (Mephitis m ephitis). The raccoons were divided into three groups of 3 
animals and on day 0, varying dilutions of a virus suspension; 1D2'4 , 1Q3A, 10u mouse 
intracerebral lethal dose~ (MICLD~), were administered into the masseter 
muscles of each animal. Three control animals received only diluent. Animals 
were observed daily and saliva and sera were collected on post-inoculation days 
35, 63 and 92 for virus isolation and determination of serum neutralizing antibody 
titer. All animals survived the 92 day observation period. One animal developed 
slowly progressive localized neurologic signs in the front legs beginning 13 days 
after challenge, yet continued to function without other clinical signs throughout 
the observation period. Two of the three animals receiving the highest inoculum 
developed serum neutralizing antibodies (SNA). Rabies virus was not detected in 
the saliva of any raccoon. On day 92, a suspension of New York City (NYC) 
strain rabies virus in fox salivary glands (1Q3.2 MICLD~) was similarly administered 
to all raccoons. Two of nine of the animals previously inoculated with the skunk 
virus survived the NYC virus challenge which killed all controls. Animals that 
survived the challenge were the ones which had developed SNA 
The results of the first inoculation demonstrate tha t given significant levels 
of skunk rabies virus, raccoons can survive at least 92 days and 22.2% of the 
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animals developed SNA. The development of SNA appears to be dose related. 
The results of the second inoculation demonstrate that animals with SNA are 
capable of withstanding subsequent challenge that is fatal for seronegative 
raccoons. 
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INTRODUCTION 
In regions with enzootic wildlife rabies, clinically normal animals may have 
serum neutralizing antibodies (SNA) against rabies (Baer, 1975; Constantine, 
1966a; Gough and Niemeyer, 1975: McLean, 1975). Serologic surveys of wild 
trapped raccoons in the United States have found seropositive prevalence rates 
ranging from 0 to 5.6% in non-enzootic raccoon rabies areas (McLean, 1975) and 
from 3 to 28% in areas with enzootic raccoon rabies (Bigler et al., 1983; Jenkins 
et al., 1988). These findings raise the question of smvivability of raccoons 
exposed to different rabies virus variants in the field. 
In experimental work designed to study species susceptibility, skunk isolates 
of rabies virus have been studied in foxes and skunks (Parker and Wilsnack, 
1966). Foxes and skunks are equally susceptible to challenge with the skunk virus 
with as little as 1()2 mouse intracerebral lethal dose.so (MICLD50) causing 83% 
mortality in both species. 
In experimental studies with virus strains other than the skunk virus, 
raccoons were found to be 1000 times more resistant than foxes to a challenge 
with a fox salivary gland isolate (Sikes and Tierkel, 1961). As few as HF mouse 
lethal dose.so (MLD50) produced 50% mortality, but 10
42 MLD.so produced only 
72% mortality in raccoons. In a separate challenge study in raccoons in Europe, 
the fatal intramuscular dose was found to be 1()3 MICLD.so of red fox virus (Artois 
et al., 1989). In other studies, raccoons remained clinically normal for 104 days 
(day of euthanasia) following challenge of 1()3 ... MLD50 Mexican free-tailed bat 
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virus (Constantine, 1966a), and for 243 days (day of euthanasia) following bites by 
rabid red bats (Constantine and WoodaJI, 1966). These data indicate that 
raccoons are somewhat resistant to certain strains of rabies virus. In contrast, a 
relatively large inoculum of 1()5..s MICLD.so of a Mexican dog virus has been shown 
to be 100% fatal in raccoons (Rupprecht et al., 1986). 
Serologic studies in other species have shown that foxes can survive an 
experimental challenge with fox virus, develop SNA, and remain clinically normal 
(Sikes 1962). Still, other skunks and foxes which subsequently died from 
challenge with fox and skunk rabies virus, also produced SNA prior to death 
(Sikes, 1962; Charlton et al., 1987). Dogs which have remained clinically normal, 
or have recovered from clinical illness have also developed SNA following 
experimental exposure to an Ethiopian rabies virus (Fekadu et al., 1982). In 
contrast, bum.an beings do not generally develop SNA until 7-10 days after the 
onset of clinical signs (Hattwick and Greg, 1975). 
There are a limited number of reports of the development and protective 
nature of SNA in raccoons. Clinically normal raccoons have been shown to 
develop SNA when experimentally bitten by rabid red bats (Constantine and 
Woodall, 1966). Raccoons have been inoculated with a salivary gland suspension 
from coyotes previously infected with Mexican free-tailed bat virus and have 
developed SNA, while remaining clinically normal (Constantine, 1966a and 
1966b ). In several challenge studies following oral vaccination with a vaccinia-
rabies glycoprotein recombinant virus vaccine, not all raccoons with SNA survived 
challenge (Brown and Rupprecht, 1990; Rupprecht et al., 1986 and 1989). 
79 
The above observations have led some to conclude that the development of 
SNA is not related to survival in experimental challenge studies, nor is the 
presence of SNA an indication of protection (Artois et al., 1989, Rupprecht et al., 
1986). 
Raccoon susceptibility to the skunk virus is unknown and little is known 
about the pathogenicity of the skunk rabies virus in raccoons. This study was 
designed to investigate the behavior of an Iowa skunk isolate of rabies virus in 
raccoons in order to determine species susceptibility and serum neutralizing (SN) 
antibody response. 
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MATERIALS AND METHODS 
Virus Inoculum and Titration 
The rabies virus suspension consisted of a homogenate of salivary glands 
from a naturally infected striped skunk submitted to the Iowa State University 
Veterinary Diagnostic Laboratory. Mandibular salivary glands were ground with 
mortar and pestle in 30 milliliters of diluent consisting of 2% normal horse serum 
in water, pH 7.6, containing 500 units of penicillin and one milligram of 
streptomycin per milliliter. The suspension was stored at -70° C until use. 
The virus suspension was titrated by intracranial inoculation in mice 
(Koprowski, 1973). Groups of ten 13-15 gram female white mice1 were 
inoculated intracerebrally with 0.03 ml of each virus dilu tion and observed for 21 
days. 50% mortality endpoint calculations were made using the Reed-Muench 
formula (Reed and Muench, 1938). 
Animals 
Twelve adul t farm-reared raccoons2 were housed individually in stainless 
steel cages, fed daily and given water ad lib. The animals were housed in an 
isolation facility, treated for parasites, identified by ear tags and weighed. Each 
animal was tested for rabies SNA 14 days prior to, and on the day of inoculation. 
Animals were randomly divided into four treatment groups of 3 animals each. 
1Sprague Dawley CF-1 mice, Harlan Sprague Dawley, Inc., Indianapolis, IN 
46229. 
2Ruby's Fur Farm, New Sharon, IA 50207. 
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Inoculation Procedure and Sample Collection 
Animals were anesthetized with a mixture of 2 mg/kg ketam.ine 
hydrochloride3, 2 mg/kg xylazine4, and 0.2 mg/kg butorphanol tartrate5 
administered intramuscularly. The rabies inoculums consisted of 1 milliliter of the 
skunk salivary gland suspension diluted to titer of 102·4,103·4,104·8 MICLD50/ mJ as 
determined by simultaneous intracerebral inoculation of mice. Each of three 
raccoons was inoculated with 0.5 ml of the virus suspension dilution bilaterally in 
the masseter muscles on day 0. Three animals received only diluent. Raccoons 
and mice were inoculated within one hour of dilution of the virus. Virus 
suspensions were held in an ice bath until inoculation. 
Animals were similarly anesthetized on days 35, 63 and 92, weighed, and 
blood samples were collected by jugular vein or cardiac puncture. Saliva samples 
were collected by swabbing the oral mucosa and tonsilar area with a sterile cotton 
swab. 
On day 92, a suspension of New York City (NYC) strain virus6 in fox 
salivary glands (103·2 MICLD50) was similarly administered to all raccoons. 
Animals were observed daily for changes in behavior. Sera were collected at the 
3Ketaset, Bristol Laboratories, Syracuse, NY 13220. 
4Rompun, Haver-Lockhart Laboratories, Shawnee, KS 66203. 
5Torbugesic, Bristol Laboratories, a division of Bristol-Myers Co., Syracuse, NY 
13221. 
6Rabies virus obtained from the National Veterinary Services Laboratories, 
Ames, IA 50013. 
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time of death. Rabies deaths were confirmed by fluorescent antibody7 staining of 
acetone fixed impression smears of brain tissue (Dean and Abelseth, 1973). 
The NYC virus challenge level for the 12 animals in this study was 
determined from a titration study in six raccoons. A raccoon lethal dose50 of 10
1
·
8 
MICLD50 of the NYC virus was determined. 
Serum Neutralizing Antibody Titer Determination 
Sera were analyzed in triplicate by the rapid fluorescent focus inhibition test 
(RFFIT), (Smith et al., 1973) for the presence of antibodies against rabies virus. 
Serial five-fold dilutions were made and the titer expressed as the geometric mean 
of the reciprocal of the highest dilution capable of reducing the number of rabies 
infected cells by 50% as determined by the Reed and Muench method (Reed and 
Muench, 1938). Test controls for the RFFIT included uninfected cell controls, 
back titration of rabies virus challenge dose, negative antirabies sera and titration 
of positive raccoon antirabies sera from raccoons previously vaccinated with a 
killed vaccine8• Sera were tested in baby hamster kidney (BHK-21(C-13)) cells9 
using a Challenge Virus Standard (CVS-11) virus6• 
7Fluorescein isothiocyanate conjugated equine or bovine ongm antirabies 
globulin, BBL Microbiology systems, Becton Dickinson and Co., Cockeysville, MD 
21030. 
8Rabguard-TC, Norden Laboratories, Lincoln, NE 68501. 
9Cells originated from the Centers for Disease Control and were supplied to our 
laboratory by the National Veterinary Services Laboratories, Ames, IA 50013. 
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Virus Isolation 
Saliva swabs were placed in one milliliter of Glasgow minimum essential 
medium10, kept in an ice bath following collection, and stored frozen (-70° C) 
until tested. Each sample was tested for the presence of rabies virus in murine 
neuroblastoma cells11 (Webster and Casey, 1988). Skunk and NYC virus 
infected cells were used as positive controls. 
10Gibco Laboratories, Grand Island, NY 14072. 
11Cells originated from the Centers for Disease Control and were supplied to our 
laboratory by the National Veterinary Services Laboratories, Ames, IA 50013. 
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RESULTS 
Skunk Virus Inoculation 
None of the animals developed fatal rabies. Raccoon #2 developed a tic in 
the left front leg on day 13 which slowly progressed into a bilateral twitch of the 
front legs and shoulders, seen when the animal was in a sitting position. In all 
other aspects, this animal behaved normally. No adverse reactions were observed 
in any of the other 11 raccoons. Virus was not detected in any of the saliva 
samples. All 12 animals continued to gain weight throughout the 92 day 
observation period. Two of the nine virus inoculated animals had developed 
SNA by day 35 and remained positive on day 63. Only one animal bad SNA by 
day 92. Table 1 gives the SN antibody levels for each raccoon. 
NYC Virus Challenge 
Two of the nine animals previously inoculated with the skunk virus survived 
the challenge. All controls (3/3) died following challenge. Challenged raccoons 
first showed clinical signs from 11 to 21 days post challenge. Sudden death was 
seen in three raccoons. Of those raccoons showing clinical signs there were 
variations, but most animals followed a pattern. Animals bad a short period of 
increased alertness or apprehension (less than 24 hours), followed by extremely 
aggressive behavior. All animals showing aggressive behaviors died within a few 
hours of the onset of these signs. Several animals were observed to drink during 
this phase. 
Table 1. Rabies virus-neutralizing antibody titer and response to challenge with two rabies viruses in raccoons 
Raccoon Inoculum• RFFIT' AntiQQd:t Titer Response to 
Group Number MICLDso DPC 35 DPC 63 DPC 92 Challengec RFFW 
A 5 <4.0 <4.0 <4.0 D (15) < 4.0 
11 235 < 4.0 < 4.0 <4.0 D(12) <4.0 
12 <4.0 < 4.0 <4.0 D(17) <4.0 
B 1 <4.0 < 4.0 <4.0 D(21) 31.5 
3 2,400 <4.0 < 4.0 <4.0 D(18) <4.0 
10 <4.0 < 4.0 <4.0 D(21) <4.0 
c 2· 7.1 4.1 <4.0 s 00 V1 
7 63,200 <4.0 < 4.0 <4.0 D(15) 32.0 
9 27.6 29.4 24.3 s 
D 4 <4.0 < 4.0 <4.0 D(14) 8.6 
6 Controls <4.0 < 4.0 <4.0 D(15) < 4.0 
8 <4.0 < 4.0 < 4.0 D(15) 5.5 
"Groups were challenged i.m. with 1 ml of a skunk rabies virus suspension. Controls received 1 ml diluent 
bVirus-neutralizing antibody titer as determined by the rapid fluorescent focus inhibition test (RFFIT) at 
specified number of days post challenge (DPC). 
cAll animals were challenged i.m. on DPC 92 with 1 ml (lQ12 MICLD50) of NYC rabies virus. S =Survived, 
D=Died. Day of death following NYC challenge is shown in parentheses. 
dVirus-neutralfaing antibody titer on day of death. 
~his raccoon developed mild peripheral neurologic signs evident since day 13 following initial inoculation. 
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None of the 7 animals which had not developed SNA following the skunk 
virus inoculation survived the NYC virus challenge. Both animals that bad 
previously developed SNA survived. Table 1 gives the post challenge results for 
each raccoon. 
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DISCUSSION 
Many factors are at work in survivability and transmission of rabies in 
different species. The geographically restricted, species specific, single reservoir 
association of rabies virus is well known (Smith et al., 1986). In addition, each 
animal species seems to have an inherent level of resistance or susceptibility to 
any rabies virus (World Health Organization, 1973). Individual animal responses 
to virus challenge complicate the pathogenesis even further. 
It is also recognized that each species adapted virus behaves differently in 
alternate hosts. In wildlife species, the variability of survival following rabies 
challenge with different virus variants is well documented (Sikes, 1962, Parker 
and Wilsnack, 1966; Sikes and Tierkel, 1961). Differing threshold levels of 
minimum virus capable of producing 100% fatality appear to exist. Other studies 
have verified how the route of exposure and method of challenge preparation can 
effect the pathogenicity (Soulebot et al., 1982). These factors, in addition to 
unknown factors in the field, add to the mystery of nonfatal rabies infection. 
Previous experimental raccoon inoculation studies have shown that they are 
relatively resistant to experimental infection with fox virus (Sikes and Tierkel, 
1961). Deaths in 100% of the animals was not seen in any dilution up to 1042 
MLD50• This study demonstrates that raccoons are resistant to inoculation with 
considerable amounts of skunk virus. The raccoons in this study were given a 
higher dose of skunk virus than was previously shown to be lethal in both skunks 
and foxes (Parker and Wilsnack, 1966). 
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Only one animal developed a neurologically related clinical sign; a slowly 
progressing twitch in the forelegs and shoulder area. It is uncertain if rabies virus 
was involved with the development of this sign. Further examination of this 
animal's neurologic system at the time of necropsy is planned. 
Serologic surveys in both raccoon rabies enzootic areas and areas with other 
species as reservoir hosts have found that normal raccoons have SNA This study 
demonstrates that experimentally infected animals can develop SNA and appear 
clinically normal. In this case 22.2% (2/9) of the animals receiving the skunk 
virus developed rabies-specific SNA. These two animals were both from a group 
of 3 raccoons that had received 104.s MICLDso of the virus. The development of 
SNA in these two animals provides supportive evidence of immune system 
infection without disease. Development of SNA in raccoons appears to be 
related to dose of virus received. Similar results have been reported in skunks 
(Charlton et al., 1987). 
Virus was not detected in any of the saliva samples. This is not unexpected 
because in other species, shedding of virus for more than a few days prior to the 
onset of clinical signs has not been reported and the route to the salivary glands 
is via the central nervous system (Schneider, 1975). 
Because of the similarity of the range distributions of striped skunks and 
raccoons in the United States, occasional exposure of raccoons to rabid skunks is 
likely. Although there is considerable variation in the amount of virus rabid 
animals excrete in their saliva, large amounts of virus can be excreted (Sikes, 
1962; Parker and Wilsnack, 1966; Vaughn, 1963 and 1965). In skunks, the range 
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is from zero to 1()4 MICLD30/0.03 mJ in saliva swab tests in skunks given a fox 
salivary gland isolate, and up to 106 MICLD30/0.03 mJ in skunks induced to 
salivate with pilocarpine (Sikes, 1962). Up to 1()53 MICLDso/0.03 ml is reported 
when the skunks infected with a skunk salivary gland isolate are induced to 
salivate with pilocarpine (Parker and Wilsnack, 1966). Such levels of virus 
excretion allows transmission with very small amounts of saliva. 
With all of the animals in this study surviving the inoculation with skunk 
virus, it appears that inapparent infections in exposed raccoons are possible. It 
would have been unusual for any of the animals inoculated with the skunk virus 
to have come down with clinical rabies after more than 92 days. Survival of these 
nine raccoons provide evidence that exposure of raccoons to rabies virus in the 
wild may be wider than previously believed. 
The results of the NYC virus inoculation indicate that animals previously 
exposed to the skunk virus can survive lethal challenge. It appears that the 
primary factor involved are SNA. 
In adclition to SNA, there are several suggested immune effector 
mechanisms involved in limiting rabies virus infection (MacFarlan, 1988). These 
include 1) mechanisms for the destruction of infected cells such as complement 
mediated cell lysis, cytotoxic T cells, or other cell mediated mechanisms; 2) 
prevention of cell to cell virus spread by sequestration of infective complexes by 
phagocytic cells or release of interferon or other soluble mediators. Although a 
protective role of cell mediated immunity has been previously reported (Wiktor et 
al., 1985), the absence of protection from the NYC virus challenge in all animals 
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without measurable SN antibody response, demonstrates that other immune 
mechanisms appear to be of limited importance in protection. Further studies 
into the mechanism of protection are required. 
Survival of some of the raccoons following the NYC virus challenge is an 
indication that the challenge was not overwhelrrung. Studies are planned to 
follow survivors and monitor the SN antibody response. 
The apparent species resistance to inoculation with skunk virus contrast 
previous reports that raccoons as a species are highly susceptible to rabies virus 
(World Health Organization, 1973), yet the results of the challenge with the NYC 
strain supported this hypothesis. It appears that the strain of the virus is a 
particularly important factor when considering raccoons susceptibility. 
Both arumals that had developed SNA survived the NYC virus challenge, 
including the animal whose titer dropped below 4.0. Similar survival results have 
been observed in foxes which developed SNA following inoculation with fox virus 
and survived a second challenge which killed all controls (Sikes 1962). In 
general, correlation between protection from challenge and SN antibody titer are 
fairly good (MacFarlan, 1988). In contrast, lack of correlation between SNA and 
protection in raccoons with vaccinia-rabies glycoprotein recombinant virus vaccine 
induced SNA has been observed (Brown and Rupprecht, 1990; Rupprecht et al., 
1989). Varying susceptibilities of raccoons to challenge viruses of different host 
origin, and efficacy of recombinant vaccines may account for the conflicting data. 
In any host, absolute correlation of protection from lethal challenge and SN 
antibody levels are lacking. This study supports the hypothesis that SNA are 
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critical to protection from challenge. 
We may never fully understand why rabies virus bas the ability to infect a 
wide range of mammals with varying incubation periods, varying species 
susceptibility, and varying virus shedding. These and other factors seem to allow 
the virus to maintain itself in low level enzootic situations, cyclical epizootic 
periods, and explosive outbreaks with waves of disease extending from epizootic 
centers. 
Knowledge of the resistance of raccoons to skunk virus and understanding 
the role of SNA helps in the interpretation of the role of the raccoon in the 
maintenance and transmission of rabies in skunk enzootic areas. 
The most important observations in this study are the resistance of raccoons 
to skunk virus, the presence of asymptomatic infection as documented by a 
measurable immune response, and survival of some animals following a lethal 
challenge. It appears that raccoons require large amounts of skunk virus in order 
to become infected and that the development of SNA in raccoons exposed to the 
skunk virus appears to be related to the dose of the inoculum. There is strong 
correlation between the development of SNA and protection from lethal 
challenge. 
Because the pathogenesis of rabies is so complicated, understanding even a 
small fraction of the dfaease in raccoons helps in the understanding of the role of 
the species in the epizootiology of rabies in the central United States. 
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SUMMARY AND CONCLUSIONS 
Rabies continues to spread and grow in the world (Beran and Crowley, 
1983) and the picture of rabies in the United States has changed dramatically in 
the last 40 years (Pacer et al., 1985). With the decrease in dog rabies, the major 
problem in North America is wildlife rabies. Raccoons have emerged as one of 
several species which are involved in this growing problem. The occurrence of 
two epizootics of raccoon rabies in the eastern United States (Jenkins et al., 
1988), bas heightened public health aspects and awareness of the importance of 
understanding the disease in raccoons. Newer diagnostic methods have also 
allowed better recognition of the epidemiology of the disease in any host. 
The problems of spreading wildlife rabies is not limited to the United States. 
In Europe, domestic animals rabies has also been reduced dramatically and rabies 
in wildlife species is expanding. Red fox rabies is found in western Europe and 
has been found to spread at a rate of 30-60 kilometers per year (Murray, 1987). 
This expanding epidemic wave has only been temporarily slowed by natural 
obstructions such as rivers and mountains. Many countries and health 
organizations are committed to eliminating canine rabies from developing 
countries throughout the world. As canine rabies is reduced, it is likely that the 
importance of wildlife reservoirs will increase as has happened in the United 
States and elsewhere. 
The geographic and species specific single reservoir association of rabies and 
animals is well recognized (Smith et al., 1986). The reason for the association of 
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particular strains of rabies variants to a particular wildlife species in geographic 
areas is unknown. Ecologic isolation preventing intra-species transmission does 
not appear to be a factor. Population studies have shown that as many skunks 
live in areas without skunk rabies as live in the central United States where skunk 
rabies is enzootic (Parker, 1975). Species susceptibility to different host adapted 
viruses appear to be the main factor for lack of inter-species transmission (Sikes, 
1962; Parker and Wilsnack, 1966). 
Raccoon rabies is not currently a problem in the central United States. 
However, with the threatened expansion of enzootic raccoon rabies, studies on 
raccoon rabies in the midwest are especially important in order to understand the 
current epidemiology of the disease in this species should a raccoon variant ever 
become established here. In other areas of the country, enzootic raccoon and 
skunk rabies areas are beginning to overlap (Smith et al., 1986), increasing the 
epiderniologic complexity of the disease. In addition, raccoon density in the 
midwest is high, raccoons are highly intelligent and live in close association with 
people in both rural and urban settings (Hoffman and Gottschang, 1977). In a 
1971 study in Florida, there were 5 person/raccoon encounters per 100,000 
people yearly (Bigler et al., 1983). In Illinois, exposure potential to rabid 
raccoons was much greater than to any other species (Schnurrenberger et al., 
1969), and in Florida during the period of 1963-1972, 65% of reported human 
exposures were from contact with raccoons (Bigler et al., 1973). 
People are also more likely to encourage the survival of the semi-
domesticated raccoon than the skunk. Raccoons are Jess likely to display the 
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furious form of rabies (Kappus et al., 1970), yet they often scratch and bite 
people who approach these animals thinking that raccoons are tame. Public 
health implications of such contacts are obvious. 
There are three basic types of information available on rabies in wildlife. 
These include reports of confirmed cases from public health and diagnosti.c 
laboratories, serologic surveys, and experimental studies. Each provide a different 
perspective in attempting to understand the epidemiology of the disease in the 
wild, but all three have drawbacks. 
The most common method of determining prevalence of rabies is with data 
from dead animals submitted to laboratories for rabies examination. These data 
provide a valuable overall picture of rabies, but there are problems with 
interpretation of these data. The unreliable nature of public health surveillance 
data due to differences in submission and reporting policies by states have been 
documented (Gremillion-Smith and Woolf, 1988). These summaries are often 
biased towards diseased animals (Woolf and Gremillion-Smith, 1986), and are not 
reliable indicators of the true prevalence of the disease among wildlife 
populations (Verts and Storm, 1966). Data from this thesis expand these findings. 
Numerous serologic studies of rabies in wildlife have been performed, and 
there are questions about the validity and interpretation of these data; especially 
studies with a significant percentage of positive arumals with low level serum 
neutralizing antibodies (SNA). This serologic survey confirms the presence of 
SNA by both the RFFIT and MSN tests and the results of the IFA test lend 
evidence that animals with low level serum neutralizing antibody titer have 
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rabies-specific immunoglobulin G. These data demonstrate that exclusion of all 
animals with low titer from serologic surveys as has been done in the past is not 
entirely appropriate. 
There have been several experimental studies on the pathogenesis of 
different rabies variants in different species. Only recently bas the raccoon 
emerged as a wildlife host and there is an incomplete understanding of the role 
raccoons play in the transmission and maintenance of rabies in wildlife in areas 
with and without enzootic raccoon rabies. 
This study demonstrates that raccoons are relatively resistant to the skunk 
virus, and that they can survive for extended periods of time following significant 
challenge. Survival of raccoons challenged with the skunk virus indicates that 
wider exposure of raccoons to rabid skunks is possible. There is also an 
indication of the presence of asymptomatic infection as demonstrated by 
measurable SNA in animals exposed to the virus. Correlation of SNA and 
protection from challenge is also demonstrated. 
It is hopeful that this study has provided some information about the basic 
dynamics of wildlife rabies. However, it is difficult to draw conclusions about 
such a complex disease from a small study in two counties in Iowa. If anything, 
the results emphasize that there are many unanswered questions about wildlife 
rabies. It is certain that many more questions will arise. Further work in the 
following areas should be considered as rabies control efforts focus on wildlife 
reservoirs. 
The occurrence of subclinical or abortive rabies needs further study. A 
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definitive answer to the question of latency of rabies in raccoons also evades us. 
If inapparent infection exists, it needs to be determined if such animals are a 
source of secondary transmission and present a source of infection to people and 
other animals. Although unexpected, it needs to be determined if such animals 
would have eventually developed fatal clinical disease, and if the distribution of 
the virus in exposed raccoons is such that it ever reaches the salivary glands. 
The overall picture of raccoon susceptibility to the rabies virus is uncertain. 
This is especially true with the skunk virus. More work in larger numbers of 
raccoons with different challenge levels are needed before definitive conclusions 
can be drawn. In addition, experimental studies in skunks with the raccoon 
adapted virus are needed as the host-associated enzootic areas of these two 
species begin to overlap. 
Virus isolation and characterization of rabies viruses isolated from raccoons 
found rabid in Iowa are needed to determine if the viruses are skunk, bat, or 
other variants. Characterization of such isolates by monoclonal antibodies could 
help determine if the skunk virus variant is the causative agent as suspected. 
Rabies virus transmission from bats to other species is rare (Tinline, 1988), but 
should be ruled out. 
The occurrence of inapparent infection in species other than the raccoon 
needs to be determined. As with raccoons, exposure of other wildlife species to 
rabies virus is unknown, but may be wider than previously believed. In the 
future, new wildlife species may emerge as primary hosts as the raccoon did 40 
years ago. Mechanisms for the adaptation of variants to the primary host should 
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be investigated. 
The mechanism of raccoon survival needs to be determined. It appears that 
rabies is not as fatal as once believed. Determination of survival mechanisms in 
animals may be helpful in treating people exposed to rabies. Current hope of 
recovery in people who develop clinical signs of rabies is infinitely small 
(Hattwick et al., 1972). 
The possible non-specific factors in raccoons sera that have virus-
neutralizing ability need further evaluation. This type of information will be 
critical in understandjng serologic based studies. Ongoing work in this laboratory, 
and reports in the literature indicate that the potential problem of non-specific 
neutralization is not limited to the raccoon. Further work with the IFA and MSN 
tests in animals with low level antibodies will also be helpful. 
It is uncertain if naturally occurring rabies-specific SNA, or if non-specific 
factors provide protection from lethal challenge. Continued trapping of raccoons 
with the hope of finding sufficient numbers of animals with these virus 
neutralizing factors for experimental evaluation may provide one means of 
determining the source and protective nature of these factors. 
Much work needs to be done before we can make conclusive statements 
about the true prevalence of rabies in any wildlife species, or the exact role of 
each species in the maintenance and transmission of the disease. 
Rabies is a successful disease. It has been around for millennia; its 
epidemiology which earlier seemed so simple is actually complex. The virus 
seems to adapt to attempts at eliminating it as evidenced by the expansion of the 
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disease in wildlife as rabies in domestic animals was brought under control. The 
expansion of rabies into wildlife reservoirs and the public health consequences of 
encounters of people and wildlife necessitate ongoing sylvatic rabies research. If 
rabies is to be eradicated from the world, an understanding of the epidemiology 
of the disease is required. Knowledge of the relationship between the virus and 
its hosts is essential if wildlife rabies control programs are to be expanded. 
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